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Abstract 
 
Tau filaments are the pathological hallmark of >20 neurodegenerative diseases 
including Alzheimer’s disease, Pick’s disease, and progressive supranuclear palsy. In the 
adult human brain, six isoforms of tau are expressed that differ by presence or absence of 
the second of the four semiconserved repeats. As a consequence, half of the tau isoforms 
have three repeats (3R tau), whereas the other half has four repeats (4R tau). 
          Site-directed spin labeling of recombinant tau in conjunction with electron 
paramagnetic resonance spectroscopy was used to obtain structural insights into tau 
filaments. The studies showed that the filaments of 4R tau and 3R tau share a highly 
ordered core structure in the third repeat with parallel, in-register arrangement of β-
strands. This structure in 3R and 4R is conserved regardless of whether full-length 
isoforms (htau40 and htau23) or truncated constructs (K18 and K19) are used. When 
mixed, 3R tau and 4R tau coassembled into heterogeneous filaments. Hence, these 
findings indicate that there are at least three compositionally distinct types of filaments: 
homogeneous 3R tau, homogeneous 4R tau, and heterogeneous 3R/4R tau.  
          In vitro experiments show that the seeded filament growth, a prerequisite for tau 
spreading in tissue culture and brain, is crucially dependent on the isoform composition 
of individual seeds. Seeds of 3R tau and 3R/4R tau recruit both types of isoforms whereas 
seeds of 4R tau can recruit 4R tau, but not 3R tau, establishing an asymmetric barrier. 
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Conformational templating of 4R tau onto 3R tau seeds eliminates this barrier, giving rise 
to a new type of tau filament.  
Conformational studies at the molecular level of tau filaments were done using 
Double electron-electron resonance spectroscopy, which allows the determination of 
distances between pairs of spin labels. These studies revealed structural differences 
between filaments of 3R tau and 4R tau. Furthermore, they indicated that 4R tau assumed 
the conformation of 3R tau when templated on 3R tau seeds. Our measurements have 
also provided insights into the heterogeneity of tau filament structure. 
Conformational differences due to variation in filament composition and seeding 
properties of tau filaments have shown that they are structurally polymorphic in nature. 
This structural polymorphism of tau filaments has widespread implications in 
understanding and treatment of neurodegenerative diseases. 
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Chapter One: Introduction 
1.1 Tau protein 
 Tau protein was first isolated in 1975 from porcine brain and given the name tau 
(τ) as it was found to induce tubule formation (Weingarten et al, 1975). Tau, a 55-62 kD 
protein (Olmsted, 1986) is incorporated into growing microtubules as an integral 
structural component and required for both initiation and elongation (Witman et al., 
1976) . Microtubules are a major component of the cytoskeletal system in eukaryotes 
(Olmsted & Borisy, 1973) and studies have shown that in the absence of tau, purified 
tubulin, a 6S dimer does not form microtubules (Olmsted & Borisy, 1973). Microtubules 
are part of mitotic and meiotic component in cells and also major component of nerve 
axons (Schmitt, 1968). Tau proteins apart from being an integral component of 
microtubules in nerve axons, support the outgrowth of axons, modulate the transport of 
vesicles and organelles along microtubules, serve as an anchor for enzymes and regulate 
the dynamics of microtubules (Cassimeris & Spittle, 2001; Drubin & Kirschner, 1986; 
Garcia & Cleveland, 2001; Weingarten et al., 1975).   
Tau protein, also referred to as microtubule associated protein (MAPT), has an 
unusual character compared to most other proteins. It is heat resistant and acid treatment 
doesn’t result in it losing its function and also it has a low content of secondary structures 
(Cleveland et al., 1977). These properties may be due to a high fraction of basic and 
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hydrophilic amino acid residues which resist the compact folding of most proteins. The 
primary sequence of tau has a low hydrophobic content (mean hydrophobicity = 0.404) 
and a net charge of +2 (Jeganathan et al., 2008). Biophysical studies have revealed that 
tau is a prototypical “natively unfolded” protein (Schweers et al., 1994) . In the human 
proteome these type of proteins have been classified as ‘‘natively unfolded’’ or 
‘‘intrinsically unstructured proteins’’ [IUPs] (Dunker et al., 2008). 
In the adult human brain, six isoforms of microtubule associated protein tau 
(MAPT) are expressed. The MAPT gene consists of 16 exons and alternative mRNA 
splicing gives rise to six tau isoforms (352-441 amino acids) (Goedert et al., 1988; 
Goedert et al., 1989). The tau isoforms are classified based on the presence or absence of 
29- or 58 amino acid insert in the N terminus and inclusion or exclusion of a 31-amino 
acid repeat segment in the C terminus. Among the six isoforms, three isoforms have four 
repeats (4R) and the other 3 isoforms have three repeats (3R) (Figure 1.1 A). In adult 
brain, transcripts coding for 4R and 3R are expressed and in fetus only the smallest 
isoform (htau 23) is expressed (Goedert et al., 1989; Goedert et al., 1989). The 3R and 
the 4R regions are characterized by a Pro-Gly-Gly-Gly motif present in each repeat 
(Goedert et al., 1988; Goedert et al., 1989). The amino acid sequence and the 
corresponding DNA sequence of the full length tau isoform 4R htau40 are given in 
Figure 1.2. The repeats carry out the major known biological function of tau: the binding 
to and stabilization of microtubules (Butner & Kirschner, 1991; Goode & Feinstein, 
1994). In disease conditions these tau monomers can aggregate to form filaments. These 
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filaments belong to the major class of amyloid fibrils which are seen in various diseases 
(Figure 1.3). 
 
 
 
Figure 1.1: Bar diagrams of tau isoforms and constructs: (A) Tau isoforms are 
defined by the presence or absence of two inserts in the N-terminal half (striped) and the 
inclusion or exclusion of the second microtubule binding repeat in the C-terminal half 
(marked as 2). Isoform sizes range from 352 amino acids (aa) to 441 amino acids and are 
provided on the right. (B) The truncated constructs K18 and K19 contain the repeats (four 
for K18 and three for K19) plus three additional residues at the C termini (Siddiqua & 
Margittai, 2010).  
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Figure 1.2: Human tau40. The complete sequence of full length tau (htau40). The 
highlighted sequence (yellow) is the second repeat. 
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For a polypeptide, its stable amyloid fibril state competes with its monomeric folded state 
(when a folded state exists), or with other nonaggregated states (Tycko, 2011). The 
relatively stable and remarkably protease resistant amyloid fibrils represent the end point 
of the protein misfolding process. Tau filaments belong to the class of amyloid fibrils 
whose formation is driven by hydrophobic interactions. The amyloid fibrils formed due 
to these misfolding processes are implicated in many neurodegenerative diseases (Figure 
1.3). Neurodegenerative diseases in which tau filaments are implicated are collectively 
referred to as tauopathies (Lee, Goedert, & Trojanowski, 2001).  
 
 
 
 
 
 
  
Figure 1.3: Major classes
implicated in major amyloid 
 
 
1.2 Tauopathies 
The neurodegenerative diseases are characterized by distinct brain lesions 
have in common the formation of filamentous deposits of abnormal proteins
heterogeneous dementias and some 
neuropathologically by prominent intracellular accumulations of abnormal filaments 
formed from the microtubule associated protein tau
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 of amyloid diseases. Tau and other proteins that
diseases.  
movement disorders, it is characterized 
 (Table 1).  
 
 are 
that 
. In 
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Table 1: Diseases in which tau inclusions have been described (M. Goedert & 
Spillantini, 2011) 
 
Alzheimer’s disease 
Amyotrophic lateral sclerosis/parkinsonism-dementia complex 
Argyrophilic grain disease 
Chronic traumatic encephalopathy 
Corticobasal degeneration 
Diffuse neurofibrillary tangles with calcification 
Down’s syndrome 
Familial British dementia 
Familial Danish dementia 
Frontotemporal dementia and parkinsonism linked to chromosome 17 
caused by MAPT mutations 
Gerstmann–Sträussler–Scheinker disease 
Guadeloupean parkinsonism 
Mytotonic dystrophy 
Niemann–Pick disease, type C 
Non-Guamanian motor neuron disease with neurofibrillary tangles 
Pantothenate kinase-associated neurodegeneration 
Pick’s disease 
Postencephalitic parkinsonism 
Prion protein cerebral amyloid angiopathy 
Progressive subcortical gliosis 
Progressive supranuclear palsy 
SLC9A6-related mental retardation  
Subacute sclerosing panencephalitis 
Tangle-only dementia 
White matter tauopathy with globular glial inclusions 
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Tau pathology is the hallmark of >20 neurodegenerative diseases, (Lee et al., 
2001). In frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP – 
17) mutations in the tau gene have been linked to the disease (Goedert & Spillantini, 
2011). The majority of tauopathies, however, develops sporadically. 
Alzheimer’s disease (AD), a major dementia, is characterized by the presence of 
two different types of deposits in the brain, senile plaques and neurofibrillary tangles 
(NFTs). The main component of senile plaques is the β amyloid peptide whereas tau 
protein is bundled into NFTs (Goedert & Spillantini, 2006; Grundke-Iqbal et al., 1986).  
NFTs which consist of paired helical filaments (PHFs) and straight filaments are 
composed predominantly of abnormally hyperphosphorylated tau proteins (Goedert et al., 
1988). Hyperphosphorylation is believed to be an early event in the pathway that leads 
from soluble to insoluble and filamentous tau protein (Braak et al., 1994). However it is 
unclear whether phosphorylation is sufficient for assembly of tau monomers into 
filaments.  
The advancing age of a person, generally 65 years or older, is a risk factor for AD 
and other dementias, but the occurrence of neurodegenerative disease is not a normal part 
of aging (alz.org). Neurodegenerative diseases have been shown not only to affect people 
in their old age but also in their young age. Brain autopsies of players of football, hockey 
and other games where the brain experiences increased incidences of concussion, the 
presence of NFTs of tau protein have been reported. This disease has been classified as 
Chronic Traumatic Encephalopathy. Autopsies of players as young as 21 years have 
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shown the presence of NFTs in the brain (Los Angeles Times, 2011; McKee et al., 2009; 
Omalu et al., 2011; Omalu et al., 2011; The New York Times, 2011). 
1.3 Architecture of Tau Filaments  
Straight filaments and PHFs  (15-20 nm diameter) isolated from brain tissue have 
a cross-β structure in which β-strands run perpendicular to the long fiber axis and are 
spaced ~4.7 Å apart (Berriman et al., 2003) (Figure 1.4). This structural feature is a 
common denominator of filaments belonging to the amyloid class (Sunde & Blake, 
1997), which are self-assembled aggregates made from proteins with diverse amino acid 
sequence (Sunde & Blake, 1998). In an amyloid fibril, two to six protofilaments (2-5 nm 
in diameter) twist around each other to form a supramolecular structure (Serpell et al., 
2000). AFM measurements have shown that the fibrils form unbranched structures with 
diameters ranging up to ~25nm. The fibrils themselves can again form large bundles. 
The precursor proteins of these fibrils have no general sequence or 3- dimensional 
(3D) structural homology in their native, soluble forms, but they all assemble into a 
cross-β-fiber structure, with β-strands perpendicular and β-sheets parallel to the long fiber 
axis.   
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Figure 1.4: Schematic structure of amyloid fiber. Arrangement of protein monomers 
in β-pleated sheet structure in a protofilament either in parallel or anti parallel β-sheet 
structure. The protofilaments twist together to form supramolecular structures called 
fibrils.  
 
When two or multiple sheets are present, they have a predominantly parallel in-
register arrangement of β-strands and usually antiparallel arrangement of β-strands is 
seen in peptides that form single β- sheets depending on the amino acid sequence 
(Margittai & Langen, 2008). 
The antiparallel β-strands are sometimes seen in aggregates formed by smaller 
peptides, but the parallel in-register arrangement of β-strands in β-sheets is seen in most 
of the amyloid fibrils. Tau filaments show parallel in-register arrangement of β-strands 
(Margittai & Langen, 2004). Aggregates of other protein filaments of Aβ (Paravastu, 
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Petkova, & Tycko, 2006), IAPP (Jayasinghe & Langen, 2004), α-synuclein (Chen et., 
2007), β2-microglobulin (Ladner et al., 2010), HuPrP (Cobb et al., 2007)  Rnq1 (Wickner 
et al., 2008) also show parallel in-register arrangement. 
Studies of β-amyloid fibrils have shown that fibrils with similar morphological 
appearance can vary greatly in molecular design; and gross morphology and fine 
structure need not be correlated (Petkova et al., 2005). Therefore, despite the shared 
similarities described amongst tau filaments in the previous paragraph, they may be 
different at the molecular level. 
1.4 Importance of study of structural polymorphism in tau filaments 
Even though tau filaments have been implicated in neurodegenerative diseases, 
their role has been controversial (Brunden et al., 2008). In particular, it has been debated 
whether filaments might have an altogether protective function by preventing individual 
tau molecules from partitioning into toxic oligomers (Bretteville & Planel, 2008).  
It has been suggested that the cytotoxicity of fibrils could be due to the number of 
misfolded forms including non-fibrillar oligomers (Chiti & Dobson, 2006). The 
importance of mature amyloid fibrils as etiological agents in AD and other amyloid 
diseases, as opposed to nonfibrillar oligomers observed at earlier stages of peptide 
incubation has been in dispute (Kayed et al., 2003; Lashuel et al., 2002). One principal 
argument against a primary role for mature fibrils in AD has been the absence of a robust 
correlation between the severity of neurological impairment and the extent of amyloid 
deposition (Kirkitadze et al., 2002). Studies have shown that certain amyloid 
morphologies may be more pathogenic than others in the affected organs of amyloid 
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diseases, which would weaken the correlation between disease symptoms and total 
amyloid deposition (Petkova et al., 2005). As a result, the structural study of fibrils gains 
importance.  
There are various reasons why the study of structural polymorphism in tau 
filaments is important. Studies in human, mouse and in vitro have revealed a direct link 
between amyloid-β and tau in causing toxicity in Alzheimer’s disease (Hardy & Selkoe, 
2002; Ittner & Götz, 2010). Tau protein is predominantly found in axons, and under some 
physiological conditions, it has also been seen to localize in dendrites albeit in lower 
amounts (Hirokawa, 1982). It mediates dendritic signaling and causes β-amyloid toxicity 
in dendrites (Ittner & Götz, 2010). In tissue culture studies, transfer of tau filaments to 
neighboring cells has been seen (Frost et al., 2009). Recent findings have suggested that 
tau filaments could play an important role in the propagation of the misfolded state of tau 
from one cell to the next (Lee et al., 2010). In addition, injections of insoluble tau into 
mouse brain resulted in the spread of misfolding through different brain regions 
(Clavaguera et al., 2009). Also it has been recently shown that tau pathology in vivo 
could spread through synapses of nerve cells (Liu et al., 2012).  
 The above mentioned properties of tau filaments are reminiscent of those 
observed in prion proteins (Prusiner, 1998). In the prion field it has been shown that the 
same prion protein due to different conformational states could result in different 
transmissible states (Prusiner, 1998). Although the overall evidence for prion-type 
mechanisms in tauopathies is scarce, it has lent a new urgency and relevance to better 
understand the structure of tau filaments.  
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There are currently 5.4 million cases of AD and related dementias in the U.S 
population (Alzheimer's association, 2011). The annual healthcare cost of this aging 
population is around $183 billion. It has been projected by 2050 that the number of 
people with AD and other dementias would be 13.2 million and the health care cost 
would be 1.1 trillion dollars. Therefore, neurodegenerative diseases are considered to be a 
major health issue (alz.org, 2011).  
For the past two decades, drug development efforts for the major 
neurodegenerative disease AD have been focused on targets defined by the amyloid 
cascade hypothesis (Hardy & Higgins, 1992; Karran et al., 2011) with disappointing 
results. Tau-based strategies, in contrast have received little attention until recently, 
despite the presence of extensive tau pathology. The discovery of mutations within the 
tau gene that causes fronto-temporal dementia has demonstrated that tau dysfunction, in 
the absence of amyloid pathology, is sufficient to cause neuronal loss and clinical 
dementia (Medina, 2011). Investigation of the fundamentals of tau polymerization is 
indispensable for identifying inhibitory conditions or compounds preventing formation of 
PHFs which may allow the slowing down or even reverse the degeneration of neurons in 
tauopathies (Andronesi et al., 2008). Considering all these, understanding the structural 
polymorphism in tau filaments could be one of the starting points to come up with better 
drugs in the future. 
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My investigations into the structural polymorphism of tau filaments are organized 
as follows: 
            Chapter 2 studies have tried to understand assembly of 3R and 4R tau isoforms in 
filaments. Continuous wave electron paramagnetic resonance (CW EPR) spectroscopy in 
combination with site directed spin labeling (SDSL) was used to study the assembly of 
these isoforms. 
Chapter 3 is related to the study of the recruitment of 3R and 4R tau isoforms into 
filaments. For this purpose, an intrinsic fluorescence assay using the environment 
sensitive dye acrylodan was developed. 
Chapter 4 is related to the study of the structure of tau filaments at the residue 
level using Double electron-electron resonance spectroscopy (DEER). 
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Chapter Two: Determination of Composition of Tau Filaments 
 
2.1 Introduction 
In the adult human brain, all six isoforms (Figure 1.1A) are present and the ratio 
of 3R and 4R tau isoforms is ~one to one (Lee et al., 2001). Antisera raised against 
synthetic peptides corresponding to different human tau isoforms have demonstrated that 
multiple tau protein isoforms (both 3R and 4R) are incorporated into the neurofibrillary 
tangles of AD (Goedert et al., 1989a; Goedert et al.,1992a; Greenberg et al.,1992). The 
relative proportions of the tau isoforms observed in AD PHFs are similar to those that are 
observed in normal adult human brain. Also different pathogenic mutations alter the 
biochemical properties and stoichiometry of tau isoforms and this has been shown by 
analysis of brains of FTDP-17 patients (Hong et al., 1998; Trojanowski & Lee, 1994). All 
these studies led us to the question, whether the 3R and 4R isoforms segregate into 
homogeneous filaments or coassemble to form heterogeneous filaments. To understand 
this phenomenon, tau aggregation was studied in vitro. 
2.1.1 Aggregation of tau filaments in vitro. 
The exact mechanism responsible for assembly of soluble tau protein into 
insoluble filaments in brain cells is not yet known. The monomeric tau proteins are 
highly soluble and form a double hairpin loop, a paperclip like structure folded in the 
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vicinity of the repeat region (Jeganathan et al., 2006), forming through transient 
intramolecular contacts (Mukrasch et al., 2009). These interactions, together with the 
overall positive charge of the protein, greatly inhibit aggregation. As a consequence a 
negatively charged cofactor (heparin) is used to accelerate aggregation.  
Heparin is a copolymer of alternating uronic acid and amino sugar residues, with 
sulfated esters in various positions (Figure 2.1). The ionized carboxylate and sulfate 
groups give it a high negative charge. The in vitro aggregation of non-phosphorylated tau 
protein into filaments is based on the electrostatic interaction of negatively charged 
heparin with the positively charged tau monomers (Calamai et al., 2006). The 
characteristics of these in vitro assembled filaments closely resemble tau filaments from 
AD brain (Goedert et al., 1996) . Other polyanions, for example, RNA, DNA, and 
arachidonic acid have also been shown to cause aggregation of tau into filaments 
(Calamai et al., 2006; Frost et al., 2009; Goedert et al., 1996). Studies have shown that 
heparin becomes integrated into the rigid core region of the PHF, probably by providing 
charge compensation for the lysine-rich stretches that form upon the stacking of the 
repeat regions (Sibille et al., 2006). Also these polysulfonated sugars have been seen in 
the plaques of many amyloid diseases (Strohmeyer et al., 2002). Binding of heparin to 
Aβ, IAPP and α-synuclein is at a higher affinity than with their monomer states. These 
observations indicate that recognition depends on the quaternary structure of the 
aggregates and therefore heparin is seen in the rigid interiors of the amyloid fibrils 
(Alexandrescu, 2005). This view is different from the observation made by some other 
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researches that heparin is not associated with tau filaments, but is only required to 
catalyze aggregation (Friedhoff et al., 1998; Jeganathan et al., 2008). 
 
 
 
 
Figure 2.1: Partial heparin structure. (Sigmaaldrich.com)  
 
When tau monomers self-aggregate into filaments, the microtubule binding repeat 
(MTBR) region has shown to be protease resistant (Goedert et al., 1988; Novak et al., 
1993; Wischik et al., 1988), thus establishing itself to be part of the structured core. The 
N- and C-terminal regions by contrast remain largely disordered, forming a fuzzy coat 
(Wischik, et al., 1988). Charge and conformational changes are of uttermost importance 
near the second (R2) and third (R3) MTBR that are thought to be involved directly in the 
nucleation of the aggregation (Friedhoff et al., 1998). Therefore to accelerate aggregation 
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of tau monomers into filaments, N and C termini are removed which is exemplified by 
the 4R and 3R constructs K18 and K19 (Figure 1.1B) (Barghorn & Mandelkow, 2002).  
2.1.2 Structure determination of tau filament. 
   Nuclear magnetic resonance spectroscopy and X-ray crystallography, which 
have been used to determine protein structures at high resolution are inadequate to solve 
structures of proteins with low solubility and those that do not form crystals. Analysis of 
tau filaments, which are aggregates, has been challenging due to their large size and low 
solubility. SDSL with CW EPR spectroscopy, which monitors structure at the backbone 
level, fills part of this gap and has been very useful in studying the structures of filaments 
(Hubbell et al., 1996; Huber et al., 2001; Margittai & Langen, 2004).  
2.1.2.1 EPR spectroscopy. 
EPR spectroscopy involves the study of energy differences due to the interaction 
of an unpaired electron in the sample with a magnetic field, B0. This effect is called the 
Zeeman Effect. The electron acts like a bar magnet when it is placed in a magnetic field 
because of its magnetic moment. Since energies are quantized, a single unpaired electron 
has only two allowed energy states. It has a state of lower energy; when the moment of 
the electron, µ, is aligned with the magnetic field and a higher energy state when µ is 
aligned against the magnetic field (Figure 2.2). The two states are designated by the 
projection of the electron spin, ms, on the direction of the magnetic field. Because the 
electron is a spin ½ particle, the parallel state has ms= -1/2 and the antiparallel state has 
ms = +1/2. The difference between the energies of these two states is caused by the 
interaction between the electron spin and the magnetic field.  
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The energy, ∆E = hν is required to cause a transition between two spin states 
∆     g BB0    and    B = eh/2me 
Where g is the g-factor, µB is the Bohr magneton which is the natural unit of the 
electron’s magnetic moment, h is the Planck’s constant, e is the electron charge and me is 
the mass of the electron and the change in spin state is ∆ms = ±1.  
                    
              
 
 
 
Figure 2.2: Zeeman energy level splitting. The energies of the two spin states of an 
unpaired electron diverge when the magnetic field is scanned. The magnetic field for 
which energy difference between the two electrons spin states is equal to hν for the 
spectrometer, absorption of energy by the spins takes place which is called as resonance. 
 
 
 
hν 
ms = +1/2 
ms = -1/2 
Magnetic Field (B0) 
∆E = hν = g µ B0 
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In Figure 2.2, it is shown that in the absence of a magnetic field the two spin 
states are degenerate and energies of the spin states diverge linearly as the magnetic field 
is increased. To obtain an EPR spectrum, the electromagnetic radiation frequency 
(microwave) is held constant and the magnetic field scanned. When the energy difference 
between the two spins states matches the energy of the applied radiation, absorption 
occurs (Figure 2.2). The field for resonance is not a unique “fingerprint” for 
identification of a compound because spectra can be acquired at different microwave 
frequencies (Eaton et al., 2009).  However, the g value is independent of the magnetic 
field.  
2.1.2.2 Hyperfine interactions. 
Additional information about the species that contains the unpaired electron can 
be obtained from nuclear hyperfine interactions. The nuclei of the atoms in a molecule or 
complex often have magnetic moments, which produce a local magnetic field at the 
electron. The interaction between the electron and the nuclei is called the hyperfine 
interaction. It gives a wealth of information about the sample such as the identity and 
number of atoms in molecule or complex that have a magnetic moment; as well as the 
electron spin density at those nuclei. When an electron spin interacts with a spin ½ 
nucleus such as hydrogen, the EPR absorption signal splits into two signals (Eaton et al., 
2009). 
2.1.2.3 Spin label, EPR spectrum of Tau filaments. 
For the study of protein structure and dynamics, SDSL in combination with EPR 
has been systematically developed (Columbus & Hubbell, 2002; Hubbell et al., 1998; 
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Hubbell et al., 1996; Hubbell et al., 2000a) and this has also proved to be an effective tool 
in the investigation of tau filaments (Margittai & Langen, 2004; Margittai & Langen, 
2006a) and other amyloid fibrils (Margittai & Langen, 2008). The spin label reports 
faithfully on the conformation of the protein backbone regardless of the size of the 
investigated species. Nitroxide scanning of a large set of spin labeled protein is done to 
determine secondary structure (Hubbell et al., 1996). The introduction of the nitroxide 
side chain is done by a common procedure in which cysteine – substitution mutagenesis 
is followed by derivatization of the reactive cysteine with a sulfhydryl-selective nitroxide 
reagent.  The reactive native cysteines are first replaced by a suitable non-reactive amino 
acid. Introduction of this spin label side chain at single sites in the structure results in a 
remarkably small degree of structural perturbation (Hubbell et al., 1996). For our studies 
nitroxide label, [1-oxyl-2,2,5,5-tetramethyl-∆3 – pyrroline-3-methyl]methanethio-
sulfonate (MTSL) was used (Figure 2.3) (Berliner et al., 1982). MTSL  attached to the 
cysteine residue has a free electron on the nitroxide group that can be detected in a 
magnetic field. The four neighboring methyl groups in the C2 and C5 positions of the 
pyrroline ring dramatically stabilize the radical, making MTSL a reliable reporter over 
extended periods. 
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Figure 2.3: Spin labeling of cysteine by nitroxide label. Derivatization of the –SH 
group of cysteine side chain with MTSL radical by disulfide linkage.  
 
EPR spectrum. 
For filament studies, CW EPR measurements at X-band (9.2 – 9.9 GHz) are done, 
where the incident wavelength is kept constant while the magnetic field is swept. The 
absorption of electromagnetic radiation is influenced by the nuclear spin of the nitrogen 
in MTSL resulting in three line EPR spectra. When an electron spin interacts with a spin 
1 nucleus (I=1), such as 14N, then the number of hyperfine lines is three (2I+1=3) in the 
absorption and its first derivative displays. The first derivatives are more commonly 
depicted than the absorption spectra because of improvement in signal to noise ratio 
(Eaton et al., 2009). The parameters that are typically extracted from CW EPR 
measurements include mobility, accessibility, distance and polarity. 
Mobility. 
In the EPR spectrum, the line shape provides valuable information on the mobility 
of the label and the local structure (Mchaourab et al., 1996). Line shapes reflect motion, 
motional anisotropy, environmental polarity, and hydrogen bonding. A line shape denotes 
an array of interacting parameters and cannot be reduced to a simple descriptive number 
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reflecting local structure (Altenbach et al., 1990). When the nitroxide label is attached to 
an unfolded site in the protein, it results in a spectrum with three sharp and narrowly 
spaced lines with large amplitude (Figure 2.4 A). On the contrary, attachment to an 
immobilized site results in broad lines, large separation of outer resonances and small 
amplitude (Figure 2.4 B). When the label is attached to surface-exposed secondary 
structures and tertiary contact sites, complex lineshapes are seen because of increase in 
immobilized sites. The spectral features mentioned reflect the mobility of the label. These 
features are quantified in terms of (1) spectral breadth (the inverse second moment <H-2> 
and (2) inverse central linewidth ∆H0-1. These quantifications allow in categorizing 
individual sites according to various backbone structures (Margittai et al., 2001; Margittai 
& Langen, 2008; Mchaourab et al., 1996). 
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Figure 2.4: EPR lineshapes. (A) Three line spectra with amplitudes are observed when 
the spin labels are attached to mobile regions. (B) Broad spectra with small amplitudes 
are seen when spin labels are attached to immobilized regions. The central linewidth is 
given as ∆H0. For comparison, the spectrum in (B) is amplified 15-fold. Outer resonance 
separations are given in gauss (G).  
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Spin exchange. 
The dipolar interactions in slow-motion regime (rigid lattice conditions) causes 
line broadening of the EPR spectrum because of the proximity of two spin labels (0.7-2 
nm). Apart from dipolar interactions, spin exchange due to orbital overlap between 
multiple paramagnetic centers is also seen (Altenbach et al., 2001; Molin et al., 1980). In 
this type of spin-spin interaction, the spectral features depend on the number of centers 
and the spatial arrangement between them. However, spin exchange is not usually 
observed in SDSL, as multiple spin label contacts are required. But in amyloid fibrils, 
spin exchange plays an important role.  
The appearance of spin exchange narrowed spectra is understood by observing the 
line shapes for radicals. The EPR spectrum of a nitroxide label shows three sharp lines 
with an intensity ratio of 1:1:1. Spin exchange results in collapse of the hyperfine lines 
and narrowing of the spectra as a result of increase in exchange frequency (Figure 2.5). 
The increased interactions between paramagnetic molecules are seen at high spin label 
concentrations and reduction of distances between them. 
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Figure 2.5: Spin Exchange and structural interpretation. Recombinant tau with a 
single cysteine at position 310 attached with paramagnetic label MTSL. After fibril 
formation in the presence of heparin and incubation for a period of 12 days, under 
agitation, EPR measurements were taken. A single-line EPR spectrum is observed 
because of spin exchange due to stacking of spin labels (yellow) in a parallel in-register 
arrangement of β strands. The scan width for the spectrum is 150 G.  
 
Biradicals and higher-order radicals with small molecular weights tumble rapidly 
in solution and as a result averaging of dipolar interactions is seen (Hanson et al., 1996). 
Crystals and amyloid fibrils do not tumble on EPR time scale and EPR spectra in these 
systems show spin exchange phenomenon. The spin exchange frequency is > 108 s-1 and 
it is also retained at lower temperatures (Margittai & Langen, 2004).  
Correlation between exchange narrowing of EPR spectrum and tau filament 
structure reported by SDSL. 
The single-line EPR spectrum was first observed in tau filaments, a signature of 
arrangement of β-strands in parallel and also in-register (Margittai & Langen, 2004). In 
tau filaments, parallel in-register arrangement of β-strands is seen when identical amino 
acids are stacked on top of each other along the length of the fiber axis (Figure 2.5). CW 
EPR studies have also shown that filaments of β-amyloid (Torok et al., 2002), α - 
synuclein (Chen et al., 2007), IAPP (Jayasinghe & Langen, 2004), β2 microglobulin 
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(Ladner et al., 2010) and HuPrP (Cobb et al., 2007) also have parallel in-register 
structure. 
At the beginning of this project EPR investigations on the structure of tau 
filaments had already been done for the 2nd repeat (Margittai & Langen, 2006a) and until 
amino acid 320 in the 3rd repeat (Margittai & Langen, 2004). In continuation, the 
complete structural study of the repeat region in 3R and 4R tau was done using SDSL and 
CW EPR. After this, the same techniques were utilized to understand the composition of 
tau filaments when mixtures 3R and 4R tau monomers form filaments. The findings of 
this study have direct implications for the structures of filaments observed in AD and 
other tauopathies.  
2.2 Methods 
2.2.1 Site directed mutagenesis. 
DNA fragments containing full length tau (htau40) and fetal tau (htau23) were 
generated by PCR amplification with primers containing NcoI and XhoI restriction sites. 
The templates used for these reactions were htau40 in pRK172 (provided by Dr. Goedert 
at the Medical Research Council Laboratory, Cambridge, UK) and htau23 in pBluescript 
(provided by Dr. Matt Farrer at the Mayo Clinic, Jacksonville, FL). The fragments were 
cloned into NcoI and XhoI restriction sites of prokaryotic expression vector pET-28b and 
site directed mutagenesis of htau40 (C291S, C322S) and htau23 (C322S) were performed 
to remove the two native cysteines (Margittai & Langen, 2004). The replacement of 
cysteine residues with serine residues was shown not to cause any effect on the 
morphology of tau filaments (Gamblin, et al. 2000). Subsequently the fragments of K18 
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and K19 were generated in the second set of PCR amplification process from htau40 and 
htau23 respectively and cloned into NcoI/XhoI restriction sites of pET-28b. Using the 
QuikChange®II Site-Directed Mutagenesis Kit method from Strategene/Agilent 
Technologies, site-directed mutagenesis was performed to introduce single cysteines in 
cysteine free htau40 and htau23. The mutant primers for the PCR reaction were ordered 
from IDT (Integrated DNA Technologies). For the PCR reaction setup, in the PCR tube 
(0.2 ml, Fisherbrand), 5 µl of 10 X Reaction Buffer (provided in the strategene kit), 
mutant plasmid 4 µl (5 ng/µL), dNTP (1 µl), PfuUltra High Fidelity DNA polymerase 
(2.5 U/ µl), mutant primers forward and reverse (0.4 µM) were added and the reaction 
volume was made up to 50 µl using H2O. The MJ MiniTM Personal Thermal Cycler (BIO-
RAD) instrument was used to perform PCR reactions. The PCR temperature parameters 
are provided in Table 2. For the PCR cycling, initial denaturation was done at 95°C. For 
the annealing of the mutant primer to the DNA template, temperatures were varied from 
55-60°C and for the elongation 68°C temperature was used. After PCR amplification, it 
was important that the parent strand be removed. Parent strand which is methylated was 
removed by digestion by DPN1 enzyme (10 U/ µl) which specifically recognizes the 
methylated sites. The PCR product was incubated with the DPN1 enzyme (1µl) for 2 hrs 
at 37°C for the digestion. For better transformation results, the salts in the PCR product 
were removed by using a purification kit from Genscript (Quickclean 5M PCR 
Purification kit) (Appendix B).  
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Table 2 
Polymerase Chain Reaction parameters used for tau mutagenesis 
Segment Number of cycles Temperature(°C) Time 
1 1 95 45 seconds 
2 17 95 45 seconds 
  
55-60 1 minute 
  
68 12 minutes 
 
 
Transformation 
Transformation of the mutant plasmid was done in XL1 Blue Supercompetent cell 
lines (Strategene kit). For the transformation 14-ml BD Falcon Polypropylene round 
bottom tubes were used. To 20 µl of XL1 Blue competent cell lines (Strategene kit), 2 µl 
of the amplified DNA (PCR product) was added and incubated on ice for 30 minutes. 
After 30 minutes, heat shock at 42°C was given to cells for 50 seconds. To the cells 800 
µl of LB medium was added and incubated in a shaker for 45 minutes at 37°C. The cells 
were plated onto kanamycin LB agar plates and incubated at 37°C for 24 hrs. The plates 
were checked for colonies and stored at 4°C. 
2.2.2 Plasmid purification, NcoI and XhoI digestion, DNA sequencing. 
A single colony from the kanamycin agar plate was picked and added to 50 ml LB 
medium, and 30 mM of kanamycin was added to it. The bacteria were allowed to grow 
for 17 hrs, cells were pelleted and plasmid purification was done using Qiagen® Plasmid 
Midiprep Kit (Appendix B).  
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A Cary-100 Bio UV-Vis spectrophotometer from Varian was used to measure the 
DNA concentration of the purified plasmid. The formula used was Unknown(µg/ml) = 
A260 x 50 µg/ml X dilution factor, where the concentration of pure double stranded DNA, 
50 µg/ml shows an absorbance at A260 = 1.0.  
To check for the correct mutant tau gene size, digestion with NcoI and XhoI 
restriction enzymes was performed. For this, 15 µl reaction volume was used. In the PCR 
tubes, 1500 ng of mutant DNA was mixed with 1.5 µl 10 X BSA, 1.5 µl 10 X NEBuffer 
2, 0.5 µl NcoI (10,000U/ml), XhoI (20,000U/ml) [ reagents from NEW ENGLAND 
Biolabs®Inc.]. The samples were incubated at 37°C for 50 minutes. After the digest, the 
samples were mixed with 4 µl sample buffer (BIO-RAD Nucleic Acid Sample Buffer 5X) 
and agarose gel electrophoresis was carried out in the presence of 250 µl  1X TBE buffer 
mixed with 10 µl of EtBr. For the gel, 1% agarose was used. For the full length tau 
fragments, BIO-RAD EZ LoadTM 1 kb Molecular Ruler and for truncated versions, K18 
and K19, BIO-RAD EZ LoadTM 100 bp Molecular Ruler was used to identify the 
fragments. Agarose gels were viewed under UV light (BIORAD trans illuminator). Based 
on the correct size of the DNA fragments, mutant plasmids were given for DNA 
sequencing at University of Colorado Health Science (CU Cancer Center DNA 
sequencing and Analysis service). Samples submitted to the sequencing facility had 2500 
ng of plasmid DNA and 30 pmoles/µl primer concentration. For DNA sequencing,  
primers T7 promoter (5’-TAATACGACTCACTATAGGG-3’) and T7 terminator (5’-
GCTAGTTATTGCTCAGCGG-3’) from IDT ReadyMade Primer were used. 
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2.2.3 Expression and purification of tau proteins. 
Expression of tau proteins was done in Escherichia coli (E.coli) strain BL21 
(DE3). An overnight start culture was prepared of E.coli. To 50 ml of the LB broth, 30 
mM kanamycin was added and a single colony of E.coli (having the required tau mutant) 
was picked and added to the broth. The overnight start culture was incubated at 37°C for 
16-17 hrs. To 1.5 L of autoclaved LB broth, 75 µM of kanamycin and 15 ml of the start 
culture was added and incubated at 37°C in a shaker until the bacterial growth reached an 
optical density between 0.8-1. After this, 1.0 mM of IPTG was added to each flask to 
induce protein expression. The E.coli expression phase was for about 3.5 hrs. The 
bacterial cells were spun down at 6000 x g for 20 minutes. The bacterial pellet was taken 
up in resuspension buffer (20 mM Pipes, pH 6.5; 500 mM NaCl, 1 mM EDTA, 50 mM β-
mercaptoethanol) and kept at -80°C for further processing. Tau protein is extremely heat 
stable (100°C, 5 minutes) (Weingarten et al., 1975). The heat stability and the high 
isoelectric points of tau protein were utilized in the purification process (M. Margittai & 
Langen, 2004).The cells were ruptured by heating at 80°C for 20 minutes and then 
sonicated for 60 sec using Fisher scientific sonifier (150 T series) at amplitude 3.  
The samples were immediately centrifuged at 15,000 x g for 30 minutes. To the 
supernatant, ammonium sulfate (55-60% m/V) was added to precipitate the proteins. 
After 1 h of salting out, the precipitate was centrifuged at 15,000 x g for 10 minutes. 
Resuspension of the precipitate was carried out in H2O with 2 mM Dithiothreitol (DTT) 
added to it. The solution was sonicated for 30 seconds, syringe filtered using Life 
Sciences Acrodisc® Premium 25 mm Syringe filter with GxF/0.45 µm GHP membrane 
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and further diluted with H2O (2 mM DTT) before loading onto the column to bring down 
the conductivity of the solution. The instrument used for purification of tau protein was 
AKTA design GE Healthcare Fast protein liquid chromatography (FPLC). Tau proteins 
were purified using cation exchange chromatography based on their isoelectric points.  
The buffers used for cation exchange chromatography were Buffer A and Buffer B with 
20 mM Pipes (pH6.5) in them. The low pH of the buffer helps to increase the positive 
charge of the tau protein. Proteins were loaded onto the Mono S column (GE Healthcare) 
and eluted by applying NaCl gradient (Barghorn & Mandelkow, 2002). The program 
used for purifying proteins by ion exchange and gel filtration is given in Appendix D. 
Protein fractions were analyzed on SDS-PAGE with BIORAD® SDS-PAGE broad range 
marker as the standard. To 6 µl of the elution fraction 2 µl of the 4X sample buffer (SB) 
was added and loaded onto 15% SDS-PAGE gel for truncated tau and 12% SDS-PAGE 
gel for full length tau. For the separation of the proteins a Mini PROTEAN II 
electrophoresis chamber (BIORAD) was used. The gel was stained using Coomassie blue 
and destained using Destain solution (Appendix A). The correct protein fractions were 
pooled and then stored at -80°C after the addition of 5mM DTT. To further purify the tau 
protein samples, gel filtration (Superdex 200 column) was carried out using Tris buffer 
(pH 7.0). Protein fractions were collected and precipitated overnight at 4°C by adding an 
equal volume of methanol with 5 mM DTT to the pooled fractions of full length tau. To 
the truncated K18 and K19, three fold excess of acetone with 5 mM DTT was added. The 
samples were pelleted and redistributed into equal aliquots. After centrifugation of the 
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protein aliquots at 15,000 x g for 10 minutes, protein pellets were stored at -80°C in 
methanol (2 mM DTT) for full length tau and acetone (2 mM DTT) for K18 and K19. 
2.2.4 Spin labeling and filament assembly of tau proteins. 
The organic solvent was removed from the stored protein pellets (4-6 mg). The 
pellets were solubilized in 200 µl GndHCl and reacted with an ~10 fold molar excess of 
either paramagnetic label MTSL or nonparamagnetic [1-acetyl-2,2,5,5-tetramethyl-∆3 – 
pyrroline-3-methyl]methanethio-sulfonate (Gross et al., 1999). Both the chemicals were 
purchased from Toronto Research Chemicals, Downsview, Canada. To attach the labels 
to the single cysteine, proteins were incubated for 1 h at 25°C in the dark. The proteins 
were passed over PD-10 desalting columns (GE Healthcare) using elution buffer (EB) to 
remove all denaturant and unreacted labels. Protein concentration of htau40 and htau23 
were measured in 6 M GndHCl by UV absorption at 276 nm (Appendix C) while K18 
and K19 concentration measurements were done using BCA assay (Pierce) (Appendix 
E).  
To set up the proteins for filament formation, 20-30 µM of protein was mixed 
with heparin (molecular mass ≈5,000 Da, Celsus, Cincinnati, OH) at a protein to heparin 
molar ratio of 4:1. The full length and the truncated versions were incubated at 25°C 
under constant stirring for 12 and 3 days, respectively. For all mixing experiments, final 
protein concentrations were 50-60 µM and the protein: heparin molar ratio of 4:1 was 
maintained. After filament formation, they were pelleted by ultracentrifugation at 
100,000 x g for 30 minutes and finally washed with EB. 
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2.2.5 Measurement of spin labeled filaments by EPR spectroscopy. 
2.2.5.1 EPR measurement parameters. 
Protein pellets were transferred into borosilicate capillaries (0.6-mm inner 
diameter X 0.84 mm outer diameter, VitroCom, Mountain Lakes, NJ). Measurements 
were carried out in a Bruker EMX spectrometer fitted with an ER 4119HS resonator. The 
experimental parameters for taking the spectra were sweep width 150 G. The microwave 
bridge parameters attenuator 12 dB, incident microwave power 12 milliwatts were used. 
In the signal channel, the receiver gain was set at 5.02 X 103, modulation frequency at 
100 kHz, modulation amplitude for filaments was set at 3 G and for monomers it was set 
at 1.5 G. The modulation phase was set at 0 deg. The offset was 0%, time constant 81.92 
msec, conversion time 20.48 msec, sweep time 41.49 sec, harmonic 1, resolution 2048 
were set. 
Data analysis was done using the software “A labview program for 
multicomponent CW EPR spectra” by Christian Altenbach, University of California, Los 
Angeles. Spectra were normalized to the same number of spins using double integration. 
A minor background originating from <0.5% soluble tau was subtracted from all spectra. 
2.2.6 Negative stain electron microscopy. 
To view the tau filaments using electron microsope, carbon coated copper with 
250 mesh grids (EM grid) (Electron Microscopy Sciences) were used. The EM grids were 
placed for 40 seconds on 10 µl drops of tau filaments (3-4 µM).  The EM grids were 
removed and adsorbed onto the filter paper before placing them on 10 µl drops of 2% 
uranyl acetate for 40 seconds. The grids were subsequently air-dried on filter paper for 10 
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minutes. All images were taken with Phillips/FEI Tecnai-12 electron transmission 
microscope operating at 80 keV equipped with a Gatan 2k x 2k CCD camera at 
University of Colorado, School of Medicine, Cell and Developmental Biology 
Department. 
2.3 Results 
2.3.1 Defining the stable ordered core in filaments of htau40. 
Previous investigations on the conformation of tau filaments have revealed that 
the third repeat of tau consists of a highly ordered core with parallel, in-registered 
arrangement of β – strands (Margittai & Langen, 2004). These studies had been done up 
to residue 320, which is the first half of the 3rd repeat. To look at the residues beyond 320 
and to understand the structure, the naturally occurring cysteine at position 322 was 
labeled with paramagnetic nitroxide label MTSL. The cross-linking of the nitroxide label 
through a thiol linkage to the protein resulted in a new side chain R1 (Figure 2.6 A). 
Before starting SDSL, the native cysteines were removed and replaced with serines to 
maintain the selectivity of the approach (Todd et al., 1989). 
When this labeled monomeric protein was measured, it produced an EPR 
spectrum of three sharp lines (hyperfine splitting of EPR spectrum because of nitrogen 
atom) characteristic of intrinsically disordered regions (Figure 2.6 B, left panel). After 
the induction of tau monomers to form filaments with heparin and 12 days of incubation 
under agitation at room temperature (25°C), EPR measurement showed a single line 
spectrum (Figure 2.6 B, right panel). This spectrum is the signature feature for parallel, 
in-register arrangement of β-strands (Margittai & Langen, 2008; Margittai & Langen, 
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2004). The results showed that the ordered core region extends beyond the previously 
published region (Margittai & Langen, 2004).The presence of filaments was confirmed 
by negative stain electron microscopy (Figure 2.6 C).  
 
 
 
 
Figure 2.6: Structural analysis of htau40 spin-labeled at position 322. (A) Labeling of 
a cysteine in the protein with the paramagnetic label (1-oxy-2,2,5,5-tetramethyl-D-
pyrroline-∆3-methyl)-methanethiosulfonate results in the side chain R1. (B) Monomeric 
tau, labeled at position 322, produces a spectrum with three sharp lines (left) 
characteristic for random structure (left insert). Formation of filaments results in a 
spectrum with a single line indicative of crystal-type order with parallel, in-register 
arrangement of β-strands (right insert). (C) Negative stain electron microscopy reveals 
twisted filaments with 15-20 Å diameter. Bar = 100nm (Siddiqua & Margittai, 2010) 
 
After seeing the parallel in-register structure at position 322, starting from 
position 321 to 358, single cysteine residues, introduced by site-directed mutagenesis 
were spin labeled. The CW spectra of labeled monomeric proteins showed three sharp 
lines, which indicated a predominance of random structure (Figure 2.7). These findings 
demonstrate that tau is an intrinsically disordered protein which is in good agreement 
with previous studies (Cleveland et al., 1977; Schweers et al., 1994). After the addition of 
heparin, filaments were allowed to form from tau monomers. When the CW EPR spectra 
of the filaments were measured, significant changes in the line shape of the spectra were 
observed. Based on the observed EPR spectra, the tau filament could be divided into two 
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distinct regions (Figure 2.8 A). The first region (residues 321-336), which extends to the 
end of repeat 3, gives rise to single-line spectra which makes this region a part of the 
highly ordered core. The second region (residues 337-358) which is a part of the 4th 
repeat produces spectra with single lines (e.g., 348), three lines (e.g., 346), or mixtures of 
both single and three lines (e.g., 357).  
Such spectral heterogeneity was previously observed in the 2nd repeat of the full 
length tau (htau40) where single amino acid substitutions had caused a conformational 
switch between stacked and disordered conformations. Based on this, it was concluded 
that the 2nd repeat is less stable and an independent domain (Margittai & Langen, 2006a). 
In line with the parallel, in-register arrangement of β-strands in the 2nd repeat, 
introduction of β-branched residues promoted folding whereas the introduction of 
charged residues prevented folding. 
The 4th repeat showed a similar trend.  The substitution of a charged amino acid, 
for example, Asp-348 with cysteine and cross linking with the spin label resulted in a 
single-line spectrum (representing ordered structure), whereas substitution of 
hydrophobic amino acid (Val-350) produced a three-line spectrum (representing 
disordered structure). Replacement of the amino acids with cysteines in the 3rd repeat 
region inadvertently resulted in a single line spectrum. The signal amplitude increases 
linearly with increasing amounts of mobile component (Margittai & Langen, 2006a; 
Margittai & Langen, 2006b).  An amplitude plot (Figure 2.8 B) shows low mobility for 
residues in the 3rd repeat and varied mobility for residues in the 4th repeat. These data, 
combined with previous observations (Margittai & Langen, 2004), reveal a stable, highly 
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ordered core structure of the 3rd repeat which is flanked by marginally stable regions that 
can switch between conformationally distinct states. 
 
Figure 2.7: EPR spectra of htau40 monomers. Single cysteine mutants of htau40 
(residues 321-358) were labeled with paramagnetic probe MTSL. All spectra were taken 
at 150 G and normalized to the same number of spins. All spectra show three sharp lines, 
which indicate a random coil structure (Siddiqua & Margittai, 2010). 
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Figure 2.8: EPR analysis of spin-labeled htau40 filaments. (A) Residues 321-358 were 
individually replaced by the side chain R1. All spectra were taken at 150 G and 
normalized to the same number of spins. The dotted line between the left and middle 
columns marks the boundary between repeats 3 and 4. (B) The amplitudes of all EPR 
spectra are plotted against the respective residue numbers. All amplitudes are normalized 
to spectrum F346R1, which has the highest amplitude (Siddiqua & Margittai, 2010). 
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2.3.2 Preservation of core structure in htau23 and smaller tau fragments. 
Investigations thus far have focused solely on the largest isoform htau40 which 
has four microtubule binding repeats. To understand whether the fetal tau htau23 (three 
microtubule binding repeats) has similar ordered core structure, six different cysteine 
positions in the 3rd repeat (positions 309, 310, 311, 317, 322 and 326) were spin labeled. 
All monomeric proteins produced EPR spectra with three sharp lines (Figure 2.9). This 
observation is in good agreement with the current data which shows that soluble tau is 
intrinsically disordered. The filament formation from monomeric tau was carried out by 
addition of heparin and then incubating the sample for 12 days. Filaments were harvested 
by centrifugation and transferred into EPR capillaries for measurement. EPR spectra of 
the spin labels at the six investigated positions were all single line (Figure 2.10, left 
column), indicating parallel, in-register arrangements of β-strands.  
The smaller fragments of tau, K18 and K19 have been used in the past as valuable 
models of tau aggregation (Barghorn & Mandelkow, 2002). To understand whether the 
smaller fragments reveal similar structural arrangement, the same set of single cysteine 
mutants were created and spin-labeled. The spin-labeled proteins in their monomeric 
form showed three sharp lines in their EPR spectrum and the filaments showed a single 
line spectrum (Figure 2.10, middle & right column). These results are similar to full 
length tau isoforms. This indicates that the parallel, in-register arrangement of β-strands 
is an intrinsic feature of the repeat region and maybe a common theme in all filaments of 
isoforms and constructs containing the stable 3rd repeat. 
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Figure 2.9: EPR spectra of htau23, K18 and K19 monomers. Single cysteine mutants 
in the 3rd repeat were labeled with paramagnetic probe MTSL. All spectra were taken at 
150 G and normalized to the same number of spins. All spectra show three sharp lines 
which indicate a random coil structure (Siddiqua & Margittai, 2010). 
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Figure 2.10: EPR spectra of filaments of htau23, K18, and K19. Residues in the third 
repeat of htau23, K18, and K19 were replaced by cysteine attached to the paramagnetic 
side chain R1. Spectra of all filaments were recorded at 150 G scan width and normalized 
to the same number of spins (Siddiqua & Margittai, 2010). 
 
2.3.3 3R and 4R tau combine to form heterogeneous filaments. 
The above data shows that the filaments formed from 3R and 4R tau are 
structurally similar.  The question that arose from this was whether these constructs could 
assemble into mixed filaments. To answer this question, in the first step, a paramagnetic 
label at position 310 of K18 was attached. A nonparamagnetic label (which produces no 
EPR signal) at position 310 of K19 was attached which resulted in a R1’ side chain 
(Gross et al., 1999). The two proteins were subsequently mixed at different molar ratios 
and heparin was added for fibrillization. After 3 days of incubation at 25°C under 
agitation condition, all filaments were pelleted at 100,000 x g and transferred into EPR 
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capillaries. At low spin concentration (10% R1), a three – line EPR spectrum was 
observed (Figure 2.11 A, red trace) with outer peak separation of 68 G. Such a spectrum 
is typical for an immobilized site with little interaction between spin labels (Margittai & 
Langen, 2006a; Margittai & Langen, 2006b). At intermediate spin concentration (60% 
R1), the spectrum broadened and the amplitude of the central peak decreased (Figure 
2.11 A, green trace). These changes are due to dipolar interactions between labels, which 
are effective at distances between 0.8 and 2.5 nm (Hubbell et al., 2000b). At high spin 
concentration (100% R1), a single-line spectrum with increased amplitude was observed 
(Figure 2.11 A, black trace). This spectrum is due to spin exchange between labels in 
close contact (Margittai & Langen, 2008). The observation of a three-line EPR spectrum 
at low spin concentration (10% R1) suggests that K18 had coassembled with K19. 
Segregation into separate filaments can be excluded as this would have retained the 
contacts between individual spin labels resulting in a single-line spectrum. To obtain a 
more comprehensive picture of the coassembly between K18 and K19, a titration series 
was performed in which the concentration of K18R1 was successively increased from 5 
to 100%. The EPR spectra of filaments were taken and amplitudes of the central lines 
were plotted as a function of the mole percent of K18R1 (Figure 2.11 B). The amplitude 
changes are similar to those that had been previously observed in other spin dilution 
experiments (Margittai & Langen, 2004; Margittai & Langen, 2008). Depending on the 
type of spin interaction that dominates at a particular dilution, different amplitudes are 
obtained: 1) large amplitudes for no interaction, 2) small amplitudes for dipolar coupling, 
and 3) slightly elevated amplitudes, and loss of hyperfine splitting, for spin exchange 
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(Figure 2.11 A). These changes occur gradually as the concentration of paramagnetic 
label increases and the average distance between individual labels decrease. Various 
spacing between labels in the differently composed filaments (Figure 2.11 B, insets I-III) 
can explain these amplitude changes. An amplitude plot that is similar to the one depicted 
here is obtained when instead of K18, K19 is attached to the paramagnetic label (Figure 
2.12). This suggests that K18 and K19 have similar probabilities of integrating into the 
filaments. To identify the core structure of heterogeneous filaments, equimolar ratios of 
paramagnetically labeled K18 and K19 were mixed. A single-line EPR spectrum was 
observed (Figure 2.11 C), suggesting a crystal-type order with parallel, in-register 
arrangement of β-strands. Electron micrographs confirmed the presence of twisted and 
bundled filaments (Figure 2.11 D). As expected, no amorphous aggregates were 
observed for sample with single line EPR spectrum (Margittai & Langen, 2004). 
In the adult brain full length versions of tau isoforms htau40 and htau23 are 
present. To look at their ability to coassemble, the same labeling strategy of K18/K19 
constructs was used. The htau40 was paramagnetically labeled while htau23 was labeled 
with non paramagnetic label. The assembled filaments produced similar spectra to those 
of the smaller constructs (Figure 2.11 E, compare with 2.11 A). Accordingly, the 
amplitude plot obtained from a titration series of these isoforms revealed the same overall 
features (Figure 2.11 F) as the one obtained for K18 and K19 (Figure 2.11 B and Figure 
2.12). Furthermore, filaments formed from an equimolar mixture of paramagnetically 
labeled htau40 and htau23 produced a single-line spectrum (Figure 2.11 G). The 
presence of filaments and absence of amorphous aggregates was confirmed by negative 
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stain electron microscopy (Figure 2.11 H). These results demonstrate that regardless of 
construct size, 3R and 4R tau coassemble into heterogenous filaments with a core 
containing parallel, in-register arranged β-strands (Margittai & Langen, 2006a). 
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Figure 2.11: Coassembly of 3R and 4R tau. (A) EPR spectra of tau filaments 
coassembled from K18R1 (paramagnetic) and K19R1’ (nonparamagnetic). The following 
mole percentages were used: 1) 10% K18R1/90% K19R1’ (red trace), 2) 60% 
K18R1/40% K19R1’(green trace), and 3) 100% K18R1 (black trace). In both constructs, 
labels were attached to position 310. (B) The amplitudes of the central lines of the EPR 
spectra in A together with those of additional dilutions are plotted as a function of the 
mole percent of K18R1. Regions in the plot in which spectra are dominated by no spin 
interactions, by dipolar coupling, or by spin exchange are interpreted in terms of different 
β-strand combinations (insets I–III). K18R1 = green arrow, yellow dot; K19R1’ = red 
arrow, black dot. (C) Spectrum of filaments formed from 50% K18R1 and 50% K19R1 
(labels attached to position 310). The inset provides a structural interpretation. K18R1 = 
green arrow, yellow dot; K19R1 = red arrow, yellow dot. (D) Electron micrograph of 
heterogeneous filaments (K18R1/K19R1). Bar = 100 nm. (E) EPR spectra of filaments 
formed from htau40R1 and htau23R1’ (all labels attached at position 310). Dilutions 
have same color coding as in A. (F) Amplitudes of central lines from filaments formed at 
different dilutions of htau40R1 and htau23R1’. (G) Spectrum of filaments formed from 
50% htau40R1 and 50% htau23R1. All spectra were taken at 150 G and normalized to the 
same number of spins. (H) Electron micrograph of htau40R1/htau23R1 filaments. Bar = 
400 nm (Siddiqua & Margittai, 2010). 
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Figure 2.12: Coassembly of K19R1 and K18R1’ into heterogeneous filaments. 
Filaments were coassembled from K19R1 and K18R1’. EPR spectra were collected and 
amplitudes of central lines were plotted as a function of the mole percent of K19R1 (red 
trace). For comparison, the amplitudes from spectra of filaments formed from different 
ratios of K18R1 and K19R1’ (see Figure 2.12B) are also plotted (black trace). The 
amplitude derived from the spectrum of filament from K19R1/K18R1’ (10%/90%) is 
arbitrarily set at 100 (Siddiqua & Margittai, 2010). 
 
2.4 Discussion 
Tau filaments are the pathological hallmark of numerous tauopathies. In most 
diseases, filaments are composed of either 3R or 4R tau, but in AD, filaments contain all 
isoforms. The isoform composition of tau filaments was determined twenty years ago 
(Goedert & Spillantini, 2006; Greenberg et al., 1992) but it was not clear whether the 3R 
and 4R isoforms in AD form homogeneous or heterogeneous filaments (Adams, et al., 
2010). This information is important as either aggregate could imply fundamentally 
different mechanisms of tau fibrillization. This study involved obtaining molecular 
insights into the structure of different tau filaments and to address the question of single-
filament composition. First, it was demonstrated that homogeneous filaments of both 3R 
and 4R tau share a highly ordered core structure that coincides with the third repeat and is 
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characterized by parallel in-register arrangement of β-strands. This conformation is 
preserved regardless of whether full-length isoforms (htau40 and htau23) or smaller 
constructs (K18 and K19) are used. Second, when 3R and 4R tau are present in the same 
sample they coassemble into heterogenous filaments. This was seen for both the full 
length tau and the truncated versions of tau. Because the heterogeneous filaments contain 
the same ordered third repeat core structure as their homogeneous counterparts, the third 
repeats of 3R and 4R tau must be able to replace each other. Together, these results 
suggest that at least three fundamentally different types of tau filaments exist: 1) 
filaments of 3R tau, 2) filaments of 4R tau, and 3) filaments of 3R/4R tau (Figure 2.13). 
This classification is based on composition and places emphasis on the core-forming 
repeat regions. 
 
 
Figure 2.13: Types of tau filaments. 3R tau (red) and 4R tau (green) assemble 
into at least three different types of filaments: 1) homogeneous filaments of 
3R tau, 2) homogeneous filaments of 4R tau, and 3) heterogeneous filaments 
of 3R and 4R tau. All filaments have in common a parallel, in-register 
arrangement of β-strands in repeat 3 (Siddiqua & Margittai, 2010). 
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Each 3R and 4R tau can represent three different isoforms that are defined by the 
inclusion or exclusion of the two inserts in the N-terminal region (Figure 1.1). This 
region is in the unstructured periphery of the filament and may not contribute to the 
stable core (Wischik et al., 1988). It is evident from the experimental data that each 
filament type can be further classified into subtypes composed of different isoforms at 
various ratios. Dilution experiments have shown that 3R and 4R tau coassemble at 
different ratios tested. As a consequence, a staggering number of filaments exist based on 
composition alone. Despite a shared parallel, in-register arrangement of β-strands, all 
three types of filaments must vary in conformation. This is because the second repeat of 
4R tau contributes to the filament core (Li et al., 2002; Margittai & Langen, 2006a). Its 
presence or absence results in different packing interactions for each filament type. For 
example, in heterogeneous 3R/4R filaments, the second repeat cannot solely pack against 
itself. Hence, 4R tau will assume different conformations depending on whether it is 
incorporated into homogeneous or heterogeneous filaments. Conformational plasticity of 
4R tau was seen when htau40 assumed different structures grown onto wild type 
filaments as opposed to mutant filaments (Frost et al., 2009). Conformational plasticity is 
a common property of amyloid proteins resulting in structurally distinct fibrils of 
homogeneously composed proteins (Colby et al., 2009; Kodali, et al., 2010a; Paravastu et 
al., 2008; Petkova et al., 2005; Tanaka et al., 2004a). It is likely that similar structural 
polymorphisms exist for each type of tau filament. Compositional diversity and 
conformational plasticity allow for a plethora of tau filament structures that may exceed 
those of other amyloid fibrils. 
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Ample experimental evidence suggests that phenotypic diversity in prion diseases 
is encoded in different misfolded conformations of the same protein (Bessen & Marsh, 
1994; Collinge et al., 1996; King & Diaz-Avalos, 2004; Tanaka et al., 2004a; Telling et 
al., 1996). Fragmentation and growth properties of different fibrils have provided a 
physical basis of how protein conformation could determine phenotype (Colby et al., 
2009; Tanaka et al., 2006). As pointed out before, the filaments in different tauopathies 
have characteristic compositions of 3R and 4R tau. Filaments in Pick’s disease contain 
3R tau. Filaments in progressive supranuclear palsy and corticobasal degeneration 
contain 4R tau. Filaments in AD incorporate both 3R and 4R tau. Since 3R and 4R tau 
coassemble in heterogeneous filaments, in AD, the filaments could be different from 
those of 3R and 4R tauopathies. It was previously shown that filaments in AD contain 
roughly equimolar ratios of 3R and 4R tau (Goedert et al., 1992a). This ratio reflects the 
expression pattern of tau in the adult human brain (Goedert et al., 1989a; Goedert et al., 
1992a; Goode et al., 2000). Hence, the majority of individual filaments in AD brain may 
be composed of evenly mixed 3R and 4R isoforms. However, because the expression 
patterns of tau isoforms can vary between different neuronal subpopulations (Goedert et 
al., 1989a), the specific composition of individual tau filaments could vary in a cell-
specific manner. The free interchangeability of 3R and 4R tau allows for a broad 
spectrum of heterogeneous filaments with diverse physical and biological properties. 
Even though the repeat region in tau may determine the stability of filaments 
(Jeganathan et al., 2008), the N-terminal inserts could still influence the interactions with 
cellular components. Here, we demonstrate that 3R and 4R tau can coassemble into 
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heterogeneous filaments, expanding the number of possible filament structures.  If future 
experiments corroborate interneuronal spreading of tau misfolding in a prion-like fashion 
(Goedert et al., 2010), the large compositional and conformational diversity of tau 
filaments could be an important contributor to the large phenotypic diversity of 
tauopathies. 
Apart from composition of 3R and 4R in tau filaments, the recruitment of 3R and 
4R monomers into filaments could also cause conformational diversity. The next chapter 
deals with the recruitment process of 3R and 4R into filaments and how it enhances the 
conformational diversity of tau filaments. 
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Chapter Three: Variations in Seeded Recruitment of 3R and 4R Tau Monomers 
into Filaments 
 
3.1 Introduction 
As already mentioned, in the adult human brain 3R and 4R tau coexist at an 
equimolar ratio (Goedert et al., 1989a) and this ratio is also reflected in the tau proteins 
found in the filamentous inclusions of Alzheimer’s disease (Goedert et al., 1992a). 
Abundant tau inclusions, in the absence of β-amyloid deposits, define Pick's disease, 
progressive supranuclear palsy, corticobasal degeneration and other diseases. In contrast 
to AD, filaments in progressive supranuclear palsy contain only 4R tau and filaments in 
Pick’s disease contain only 3R tau (Buée & Delacourte, 1999). The molecular basis for 
this difference in tau deposition in neurodegenerative diseases is not yet understood and 
maybe understanding the recruitment of 3R and 4R tau monomers into filaments would 
give a clue of why this difference in deposition of 3R and 4R is seen in various diseases. 
3.1.1 Nucleated versus seeded tau filament formation. 
In vitro assembly of tau filament formation (as that of other amyloid fibrils) 
depends on the assembly of a critical nucleus onto which individual monomers can grow 
(Figure 3.1). This nucleation event requires the cooperative interaction of a few 
monomers to form oligomers which constitutes an initial lag phase in the formation of 
filament. Also this nucleation event is concentration dependent.  After the nucleation 
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process, filament elongation is a fast process. The nucleation event marks the rate – 
limiting step of fibril formation that can be circumvented by the addition of seeds 
(Friedhoff et al., 1998; Nonaka et al., 2010). These in vitro aggregation features makes 
this fibril assembly broadly similar to that of amyloid fiber aggregation in AD or other 
aggregation processes in different neuronal disorders (Friedhoff et al., 1998).  
 
 
Figure 3.1: Nucleated versus seeded formation of tau filaments (Not drawn to scale). 
 
3.1.2 Spread of tau filaments. 
There are various reasons for studying seeded in vitro reactions. Studies have 
shown that filaments can transfer among neighboring cells in tissue culture (Frost et al., 
2009). The injection of brain extract from mutant P301S tau-expressing mice into the 
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brain of transgenic wild-type tau-expressing animals was shown to induce the assembly 
of wild-type human tau into filaments and the spread of pathology from the site of 
injection to neighboring brain regions (Clavaguera et al., 2009). Also studies in mice 
have shown that cognitive impairment becomes manifested when tau inclusions reach the 
hippocampus from other regions of the brain. These abundant neocortical tau inclusions 
and extracellular β-amyloid deposits found in mouse brain resembles the pathology seen 
in AD (Clavaguera et al., 2009).  
Recent studies have shown that the introduction of minute quantities of misfolded 
tau filaments into tau-expressing cells rapidly recruits large amounts of soluble tau into 
filamentous inclusions resembling NFTs. This efficient recruitment of tau monomers into 
filaments suggests a “seeding”-recruitment process as a highly plausible mechanism 
underlying NFT formation in vivo (Guo JL & Lee VM, 2011). The spontaneous uptake of 
tau filaments into cells is most likely mediated by endocytosis, suggesting a potential 
mechanism for the propagation of tau lesions in tauopathy brains (Guo JL & Lee VM, 
2011).  
Analysis of diseased brain tissues of humans have shown that in the disease 
process neuronal tau inclusions first appear in the transentorhinal cortex, from where they 
spread to the hippocampus and neocortex (Braak & Del Tredici, 2011). The spreading of 
tau filaments is reminiscent of the (interneuronal) spreading of prions, which raises the 
important question of whether prion-like mechanisms are responsible for tau 
pathogenesis (Goedert et al., 2010; Prusiner, 1998). Prion diseases, unlike tauopathies, 
are infectious. However, infectivity and interneuronal transmissibility of prions are 
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thought to be based on a single molecular principle: recruitment of monomeric proteins 
onto the filament ends. Understanding this recruitment process for tau may provide 
important molecular insights into the interneuronal spreading of tauopathies. 
3.1.3 Study of recruitment of tau monomers into filaments 
To study the recruitment of 3R and 4R tau monomers by seeds of tau filaments, 
truncated versions of full length isoforms K18 and K19 were used (Figure 1.1). As the 
aggregation kinetics of K18 and K19 is faster than that of full length htau40 and htau23, 
the former constructs have been used as model systems for the aggregation of 3R and 4R 
tau (Barghorn & Mandelkow, 2002). 
3.1.3.1 Study of tau aggregation. 
Previous studies on aggregation kinetics of proteins into amyloid fibrils have been 
done using Thioflavin T assay (Khurana et al., 2005). This assay uses thioflavin T (ThT), 
a thiobenzaldehyde dye which associates rapidly with aggregated fibrils of synthetic 
peptides and gives rise to a new excitation (ex) (absorption) maximum at 450 nm and 
enhanced emission (em) at 482 nm, as opposed to the 385 nm (ex) and 445 nm (em) of 
the free dye (Levine III, 1993). This change is dependent on the aggregated state as 
monomeric or dimeric peptides do not show this effect (Levine III, 1993). Also thioflavin 
T, has been visualized bound along the fibrils using atomic force microscopy (Khurana et 
al., 2005). 
For our studies of kinetics of aggregation of tau monomers into filaments a 
fluorescence assay using acrylodan was standardized. Acrylodan is an environment 
sensitive dye and its behavior in solvents is explained in the following section. 
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3.1.3.2 Monitoring of General solvent effects on Acrylodan by Fluorescence 
Spectroscopy. 
 
The general solvent effects on acrylodan fluorophore can be explained by a 
Jablonski diagram (Figure 3.2). 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2: Jablonski diagram for fluorescence with solvent relaxation.  
 
 
Fluorescence is the emission by a fluorophore of a photon from the lowest excited 
state S1 to the ground state S0. Emission of a photon occurs with a certain energy E and 
which can be observed at a certain wavelength λem. Because of the vibrational levels 
fluorescence is seen at longer wavelengths than the first singlet absorption. Solvents also 
have an effect on the position of the fluorescence band and many studies on 
biomacromolecules have exploited this fact. One aspect of the solvent effect is the 
General solvent effect which depends on the polarizability of the solvent, and increasing 
 
hν’
 (10-9s) 
More polar 
solvent 
Less polar solvent 
 µE 
 µG 
 hνF 
 (10-15s) 
 hνA 
Internal conversion and 
vibrational relaxation              
(10-12s) 
Solvent  
relaxation               
(10-10s) 
 S2 
 S1 
57 
 
the dielectric constant usually shifts the fluorescence to longer wavelength (Figure 3.2). 
General solvent effects involve the interaction of the permanent dipole moment of the 
molecule in both the ground and excited states with the reactive field induced in the 
surrounding solvent.  
The Franck-Condon principle states that during electronic transitions nuclei do 
not move, but the electrons of the solvent molecules redistribute themselves around the 
new excited state dipole. Also, because of the long lifetime of the excited state (10-8 s), 
before the emission of the fluorophore, the solvent molecules reorient to their equilibrium 
position around the excited state of the fluorophore (Figure 3.3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Figure 3.3: Dipole in a dielectric medium.
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transition energy. This occurs because the electrons in the solvent follow the rapid change 
in the electron distribution within the fluorophore as shown in Figure 3.3. On the 
contrary, the orientation of the solvent molecules, during the absorption of light does not 
change.  
Tau filament aggregation was studied by attaching the acrylodan fluorophore to 
the cysteine residue in the monomer. Since the acrylodan fluorescence emission is highly 
sensitive to its local environment, when bound to a protein it exhibits changes in both 
intensity and emission wavelength that reflect the degree of solvent exclusion and the 
effective dielectric constant of the environment of the fluorophore (Hibbs et al., 2004; 
Wearsch et al., 1998).  
3.2 Methods 
3.2.1 Site directed mutagenesis, protein expression and purification. 
Site directed mutagenesis, protein expression and purification were done using the 
protocols given in chapter 2 sections 2.2.1, 2.2.2 and 2.2.3. 
3.2.2 Seed production. 
In a 2 ml eppendorf vial, 1500 µl of 25 µM cysteine free K18 and K19 (or a 
combination of 12.5 µM K18 and 12.5 µM K19) were mixed with a twofold molar excess 
of heparin (50 µM) (average molecular mass of 5000 Da, Celsus, Cincinnati, OH) and 
allowed to grow under agitation at room temperature (25°C) for 3 days. Subsequently, the 
filaments (500 µl) were kept on ice for half an hour and then sonicated on ice for 20 
seconds using Fisher Scientific Sonifier (150 T Series) at power setting 3. The seed 
morphology was verified by negative stain electron microscopy (Figure 3.4). For 
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multiple steps of seeded reactions, filament formation was allowed for 1 h and then they 
were sonicated to produce seeds for the next reaction. 
 
Figure 3.4: Electron micrograph of filament seeds. The filament seeds are produced by 
ultrasonic shearing of seeds. 
 
3.2.3 Seeding assay and fluorescence detection. 
3.2.3.1 Acrylodan assay. 
The following mole percentages were used for all reactions: 2% acrylodan-labeled 
tau, 98% cysteine-free tau. The final concentration of monomeric proteins K18 and K19 
was 10 µM. For the fibrillization process 2 fold molar excess of heparin to tau was added. 
Initiation of the seeding reactions was done by the addition of 3 mol% seeds. 
Experiments that required multiple cycles of seeding and elongation contained higher 
concentration of monomers (25 µM) and larger mole percentages of seeds (8%). After 
one hour of fibrillization, each reaction was sonicated to produce seeds for the next 
reaction cycle. The final seeding step in this multicycle procedure contained 3 mol% 
seeds and 10 µM monomers. All reactions were monitored in a Fluorolog 3 system 
(Horriba, Jobin). Temperatures were controlled at 37°C using a solid state Pelletier 
200 µm 
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element. The fluorophore was excited at 360 nm and single emission spectra were 
measured from 400-600 nm with excitation and emission slit widths set at 5 nm. 
3.2.3.2 Thioflavin T seeding assay. 
The filament formation was monitored by the change in ThT fluorescence upon 
ThT binding to tau filaments (Maskevich et al., 2007; Naiki et al., 1989). Reactions were 
carried out in a HEPES buffer (100 mM NaCl, 10 mM HEPES, pH 7.4) at 37°C, with 
5µM ThT. Tau (10 µM K18 or K19) was pre-incubated for 5 min at 37°C, whereupon 
reactions were initiated with 3 mol% of respective seeds. All reactions contained two fold 
molar excess of heparin (average MW = 5000) to monomeric tau. Fluorescence was 
measured using a Fluorolog 3 spectrofluorometer (Horiba Jobin Yvon), with the 
excitation wavelength set at 440 nm and the emission wavelength set at 480 nm. The 
excitation and emission slit widths were 5 nm. 
3.2.4 Negative stain electron microscopy. 
The method used here has already been mentioned in Chapter 2 section 2.2.6. The 
tau filament concentration used was 10 µM. 
 
3.3 Results 
3.3.1 Seeds of 3R/4R Tau Nucleate the Formation of 3R and 4R Tau 
filaments. 
 
In the previous chapter we showed that the mixing of 3R and 4R tau monomers 
causes them to coassemble into heterogeneous filaments rather than segregate into 
separate filaments. Whether these coassembled filaments can effectively seed the 
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propagation of individual 3R and 4R tau monomers is not known. For the studies, 
acrylodan was cross-linked to a single cysteine (Figure 3.5 A) at position 310 in the third 
repeat of K19. This site was chosen as it is located in the core of the filament (Andronesi 
et al., 2008; Margittai & Langen, 2004) and as such is expected to have different polar 
environments in monomers versus filaments. Furthermore, spin-labeling of the site had 
no measurable effect on overall structure as shown in chapter 2. The reaction with 
acrylodan resulted in a new side chain, henceforth referred to as A1.  For the filament 
formation, the labeled protein was mixed with a 50-fold molar excess of cysteine-free 
K19. The fluorophore labeled sample was excited at 360 nm and the emission spectrum 
was measured from 400 – 600 nm. The emission spectrum had a maximum at 523 nm 
(Figure 3.5 B) which is characteristic of a solvent exposed site (Wearsch et al., 1998). 
This result is in agreement with tau being an intrinsically disordered protein (Cleveland et 
al., 1977; Schweers et al., 1994).  
The addition of seeds that were produced by ultrasonic shearing of K18/K19 
filaments and heparin (2 fold molar excess to the protein) initiated the aggregation of tau 
monomers. Upon completion of the fibrillization process, the emission spectrum blue 
shifted to 462 nm (Figure 3.5 B), indicating label exposure to a more hydrophobic 
environment (Wearsch et al., 1998). The reciprocal of the wavelength for the emission 
maximum was plotted as a function of time revealing elongation kinetics of K19 (Figure 
3.5 C). Similarly, when K18 was allowed to grow on K18/K19 seeds the elongation 
kinetics were similar to K19 on K18/K19 seeds. In the absence of seeds, aggregation of 
neither K18 nor K19 on K18/K19 seeds was seen. The presence of filaments in the 
63 
 
seeded reactions was confirmed by negative stain electron microscopy (Figure 3.5 D, E). 
Together, these findings suggest that the filaments of 3R/4R tau serve as seeds for the 
formation of 3R and 4R tau filaments. 
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Figure 3.5: Seeds of K18/K19 effectively template growth of K18 and K19. (A) 
Scheme of acrylodan labeling of cysteine side chain. (B) Addition of 3% K18/K19 seeds 
to a mixture of monomers of 98% K19 and 2% K19_310A1 (total concentration: 10 µM) 
results in a time-dependent blue shift in the emission maximum. Traces from right to left 
represent reactions after 0, 0.5, 5, 10, and 80 min. Excitation: 360 nm, Emission: 400-
600nm. (C) The reciprocal of wavelength plotted as a function of time reveals the 
progression of K19 (red trace) and K18 (black trace) aggregation. In the absence of seeds 
no changes are observed. Values represent mean ±s.d (n = 3 experiments). (D, E) 
Electron micrographs of K18 and K19 filaments produced through K18/K19 seeded 
reactions (Dinkel et al., 2011). 
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3.3.2 Cross-seeding barrier prevents growth of 3R tau onto 4R tau seeds. 
When compared to K18, K19 lacks the 2nd microtubule binding repeat (Figure 
1.1B). To determine whether this variation affects the filament conformation, the seeding 
properties of K18 and K19 filaments were tested. In the first set of experiments, the 
elongation kinetics of K18 and K19 on K18 seeds was monitored. The acrylodan 
fluorophore was attached to position 310 of both K18 and K19 to report the fibrillization 
process. A 50-fold molar excess of K18 and K19 cysteine-free protein was mixed with 
K18_310 A1 and K19_310 A1 respectively.  The results showed that K18 grew on K18 
seeds while K19 did not grow on K18 seeds (Figure 3.6A). An increase in the 
concentration of seeds by 3- or 5-fold did not lead to incorporation of K19 monomers on 
K18 seeds, which indicates a robust conformational barrier (Figure 3.7 A). The 
attachment of label to different positions of the K19 was checked to see whether this 
conformational barrier was due to labeling at position 310 (Figure 3.7 B). These labeled 
K19 monomers (317, 322) also failed to form filaments. Electron micrographs confirmed 
this seeding behavior as filaments were observed for K18 (Figure 3.6 B), but not for K19 
(Figure 3.6 C). In the next step, seeds from K19 were produced, and K18 and K19 
allowed to grow on them. Both K18 and K19 grew on K19 seeds but the incorporation of 
K19 monomers was markedly more efficient (Figure 3.6 D). The filamentous nature of 
the aggregates was confirmed by electron microscopy (Figure 3.6 E, F). In order to 
verify the seeding properties of K18 and K19 independently, all experiments were carried 
out using an extrinsic thioflavin T based assay (Figure 3.8 A, B). The same asymmetric 
barrier was observed. Furthermore, replacement of the truncated monomers with full-
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length versions of tau (htau23 and htau40) produced similar seeding characteristics, albeit 
with slower kinetics (Figure 3.9 A, B). Combined, these data suggest that conformational 
differences between filaments of 3R and 4R tau allow growth of 4R tau onto 3R tau seeds 
but prevent the growth of 3R tau on 4R tau seeds.  
 
 
 
Figure 3.6: Asymmetric barrier for K18 and K19 cross-seeding. (A) Aggregation of 
K18 monomers (98% K18, 2% K18_310A1) and K19 monomers (98% K19, 2% 
K19_310A1) in the presence of 3% K18 seeds. (B) Electron micrograph of K18 filaments 
seeded with K18. (C) Electron micrograph of K19 grown onto K18 seeds. (D) 
Aggregation of K19 monomers (98% K19, 2% K19_310A1) and K18 monomers (98% 
K18, 2% K18_310A1) in the presence of 3% K19 seeds. (E) Electron micrograph of K18 
grown onto K19 seeds. (F) Electron micrograph of K19 grown onto K19 seeds. Protein 
concentrations were 10 µM. All values represent mean ±s.d. (n = experiments) (Dinkel et 
al., 2011). 
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Figure 3.7: Robust asymmetric barrier for K18 and K19 cross-seeding. (A) A robust 
barrier prevents growth of K19 monomers onto K18 seeds. Circles = 9% seeds, diamonds 
= 15% seeds. Growth of K18 monomers onto 3% K18 seeds (triangles) is reproduced 
from figure 3.6 A and shown for comparison. In all samples acrylodan is attached to 
position 310. (B) K19 aggregation monitored through acrylodan-labeled constructs 
K19_317A1 (circles) and K19_322A1 (squares) indicates that regardless of the position 
that is labeled, K19 does not grow onto K18 seeds. Growth of K18 onto K18 seeds 
(triangles) is depicted for comparison. In all cases 3% seeds are added to 10 µM 
monomers (Dinkel et al., 2011). 
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Figure 3.8: Seeded filament growth monitored with Thioflavin T (5 µM). 
 (A) Changes in fluorescence intensity indicate that K18 monomers grow onto K18 seeds, 
but K19 monomers do not. (B) ThT fluorescence reveals growth of K19 monomers onto 
K19 seeds and reduced growth of K18 monomers onto K19 seeds. In all ThT 
experiments, 3% seeds are added to 10 µM monomers. All values in A, B represent mean 
± s.d. (n = 3 experiments) (Dinkel et al., 2011). 
 
 
 
A 
B 
69 
 
 
 
 
 
 
 
 
    
 
 
 
Figure 3.9: Full length aggregation kinetics of htau40 and htau23. (A) Aggregation of 
htau23 monomers (98% htau23, 2%htau23_310A1) in the presence of 8% K19 seeds or 
8% K18 seeds. (B) Aggregation of htau40 monomers (98% htau40, 2% htau40_310A1) 
seeded by addition of 8% K18 seeds or 8% K19 seeds. Monomer concentrations are 
20µM. All values in A, B represent mean ± s.d. (n = 3 experiments) (Dinkel et al., 2011). 
B 
A 
70 
 
3.3.3 Cross-seeding gives rise to a new type of 4R tau filament. 
The observation that 4R tau can grow onto 3R tau seeds raised the question of 
whether the resulting filaments have the ability to seed 3R tau. Such a property would be 
expected if the monomers of 4R tau assumed the conformation of the seeds of 3R tau. In 
order to address this question, a three step seeding experiment was carried out (Figure 
3.10 A). In the first step K18 monomers were grown on K19 seeds. In the second step 
three cycles of seeding and elongation produced an enriched population of K18 filaments. 
In the third step seeds of these K18 filaments were added to K19 monomers. Remarkably, 
the K18 seeds had the ability to seed the formation of K19 filaments (Figure 3.10 B, top 
trace). As a result of the multistep procedure the concentration of K19 seeds was reduced 
from 2.0 X 10-6M in the first reaction to 3.1 X 10-11M in the final reaction. At this final 
seed concentration K19 does not accelerate aggregation, therefore the growth of K19 
monomers was not affected by any residual K19 seeds. The presence of filaments was 
confirmed by EM (Figure 3.10 C). Importantly, when the initial seeds in the multistep 
seeding procedure were composed of K18, seeding of K19 in the final step did not occur 
(Figure 3.10 B, bottom trace). Corresponding results were obtained when the full length 
tau was used in the final elongation step (Figure 3.11 A, B). These observations are 
important as they demonstrate that the same protein, K18, can produce filaments with 
different seeding properties, depending on the initial template, and furthermore that these 
properties can be propagated over multiple generations.  
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Figure 3.10: Tau filament diversification. (A) Experimental design of multicycle 
seeding reactions. Each time seeds from the previous reactions were used to form new 
filaments. (B) Aggregation of K19 monomers (98% K19, 2% K19_310A1) in the 
presence of 3% K18 seeds (last step in A) monitored as a change in the reciprocal of 
emission wavelength over time (top trace). When instead of K19 seeds K18 seeds were 
present in the initial step, no aggregation was seen (bottom trace). (C) Electron 
micrograph representing the end point of the top trace in (B) (Dinkel et al., 2011). 
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Figure 3.11: Tau filament diversification in full length tau. A multi-cycle seeding 
procedure as outlined in Fig. 3.10 A is used with the only difference that seeds (8 mol %) 
in final reaction are added to htau23 (20 µM) instead of K19. (A) Aggregation of this 
reaction (98% htau23, 2% htau23_310A1) is monitored as a change in reciprocal 
emission wavelength over time (red). When initial seeds in this five-step procedure are 
K18 and not K19 filaments, aggregation does not occur (black trace). (B) Electron 
micrograph representing the end point of the red trace in A (Dinkel et al., 2011). 
 
 
3.4 Discussion 
The identification of three compositionally distinct types of tau filaments that 
share a common core with parallel, in-register arrangement raised the question of whether 
these filaments could be conformationally distinct. In filaments, variations in packing 
interactions could impart different biophysical properties to them. To identify differences 
between the three types of filaments their seeding characteristics were studied. Recent 
evidence suggests that caspase-cleaved fragments (De Calignon et al., 2010), and other 
truncated forms of tau (Wang et al., 2007), may play a critical role in the initiation of 
filament formation. These smaller forms accelerated kinetics and therefore seeds may 
serve as templates onto which full-length isoforms bind (De Calignon et al., 2010; Wang 
et al., 2007). For seeds, the constructs K18 and K19 were chosen, which are truncated 
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versions of tau that contain the core-forming repeat region (Figure 1.1B). The following 
key observations were made irrespective of whether truncated (K18 and K19) or full-
length versions of tau (htau23 and htau40) were used for filament growth (summarized in 
Figure 3.12): First, seeds of 3R tau and 3R/4R tau recruit both types of isoforms. Second, 
seeds of 4R tau recruit 4R tau and 3R/4R tau, but not 3R tau, establishing an asymmetric 
barrier. Third, conformational templating of 4R tau onto 3R tau seeds abolishes this 
barrier giving rise to a new type of tau filament. These results indicate the existence of at 
least four conformationally distinct types of filaments. 
 
 
 
Figure 3.12: Templated filament growth of tau. Monomers of 3R and 4R tau (top) can 
grow only on the ends of 3R (blue), 3R/4R (yellow) and 4R filaments (green and pink) if 
their sequence is compatible with the conformation of the seed (arrows). Structural 
incompatibility gives rise to a seeding barrier (crossed out arrow) (Dinkel et al., 2011). 
 
Conformationally distinct fibrils are a hallmark of prions and are thought to be the 
basis for strain (or phenotype) variations in mammals (Colby et al., 2009; Legname et al., 
2006) and yeast (King & Diaz-Avalos, 2004; Tanaka et al., 2004a). Strain identity is 
thought to be maintained by imprinting the conformation of the prion fibril onto the 
soluble prion proteins via seeded conversion (Castilla et al., 2008; Jones & Surewicz, 
2005). Prion proteins that vary in sequence may also be recruited giving rise to the 
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transmission of prions from one species to another or, in the case of polymorphisms, the 
transmission within species (Collinge, 2001). This process can lead to the emergence of 
new strains as exemplified by the appearance of variant Creutzfeld Jacob’s disease, 
which has been linked to the transmission of bovine prions to humans (Collinge et al., 
1996). If the primary structure of the variant is incompatible with the conformation of the 
seed, a transmission barrier occurs. The seeding barrier that prohibits 3R tau from 
growing onto 4R tau seeds is reminiscent of such a barrier, suggesting that the primary 
structure of 3R tau is incompatible with the conformation of 4R tau seeds. The primary 
structure of 4R tau, however, is compatible with the conformation of 3R tau seeds, 
leading to the emergence of a new type of filament. An asymmetry in seeding specificity, 
similar to that observed for 3R and 4R tau, has been described for the tau disease mutant 
P301L (Aoyagi et al., 2007). While the seeds of this mutant recruited its respective 
monomers, wild type monomers were not recruited. Wild type seeds, on the other hand, 
were able to recruit both mutant and wild type tau. Whether P301L that had been grown 
onto the wild type seeds resembled a new type of filament that was able to seed wild type 
tau has not been addressed. Regardless, these findings demonstrate that the coexistence of 
different tau isoforms and the presence of tau mutants could have intricate effects on the 
propagation. 
On the basis of their seeding properties, we have identified four conformationally 
distinct types of filaments (Figure 3.12). It is likely that additional types of filaments 
exist. Previous experiments have demonstrated that 4R tau can adopt different 
conformations when grown onto distinct seeds (Frost et al., 2009; Colby et al., 2009), 
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revealing a structural plasticity of tau akin to that of other amyloid proteins (Colby et al., 
2009; Kodali et al., 2010a; Paravastu et al., 2009; Petkova et al., 2005; Tanaka et al., 
2004a). The in vitro conditions that were used for filament formation arguably do not 
recapitulate the complex biochemical environment in the human brain. Cofactors, 
chaperones, and post-translational modifications could affect filament formation in a cell-
dependent manner. In fact, in the case of prions it has been shown that different cell lines 
can favor different prion strains (Mahal et al., 2007) and that selective pressures can 
cause the amplification of new strains and the disappearance of old ones (Li et al., 2010). 
Despite their deficiencies, our in vitro experiments have demonstrated that tau filaments 
have the ability to seed, propagate, and diversify and that conformational barriers can 
determine isoform recruitment. Our experiments suggest that the initial nucleation event 
may have a profound effect on subsequent filament formation. Nuclei that contain 3R and 
4R tau could establish templates that recruit all isoforms. Such a type of recruitment 
could be important in AD where all isoforms are deposited (Goedert et al., 1992a). Nuclei 
that contain only 4R tau could establish templates that recruit only 4R tau. Importantly, 
such a conformational barrier could explain the preferential deposition of 4R tau in 
progressive supranuclear palsy, corticobasal degeneration, and other 4R tauopathies. 
Although our in vitro experiments do not explain the preferential deposition of 3R tau in 
Pick’s disease, it is possible that inefficient growth of 4R tau onto 3R tau seeds leaves 
these filaments prone to cellular clearance. Alternatively, an additional type of 3R tau 
filament may exist that is conformationally incompatible with 4R tau. Despite this lack of 
understanding, the molecular mechanisms that explain strain diversity, transmission 
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barriers, and strain emergence in prion diseases are clearly inherent in tau, suggesting that 
similar phenomena might exist in tauopathies. 
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Chapter Four: Study of Tau Conformers by DEER 
 
4.1 Introduction 
Amyloid fibrils may show polymorphism by (1) distinct modes of lateral 
association of protofilaments without significant variation in molecular structure 
(Jiménez et al., 2002) or (2) distinct morphologies can also result from significant 
variations in molecular structure at the protofilament level (Petkova et al., 2005). Studies 
in the previous chapter have shown that the seeds of K18 (4R) can recruit only 4R 
monomers while the seeds of K19 (3R) can recruit both 3R and 4R monomers. The 4R 
monomers do grow on K19 seeds albeit in slower manner when compared to the growth 
of 3R monomers on K19 seeds (3R). The conclusion of the study was that the 3R seeds 
were able to conformationally template 4R monomers. To study these conformationally 
different tau filaments at the molecular level, PELDOR or DEER (double electron- 
electron resonance spectroscopy) was utilized. 
4.1.1 Double electron-electron resonance spectroscopy. 
 Solid state NMR has been used to study the structures of fibrils at the molecular 
level. Recent work in solid state NMR has demonstrated the feasibility of estimating 
electron-nucleus distances in proteins in the 1–2 nm  range (Helmus, et al., 2008; Tycko, 
2011) while DEER in favorable cases can measure up to 6 nm in proteins (Dockter et al., 
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2009; Jeschke et al., 2005; Pannier, et al., 2000). Therefore when compared to solid state 
NMR, DEER is a better technique to pick up long range distance changes which could be 
a better reflection of structural changes in filaments. 
DEER is a similar technique to Forster resonance energy transfer (FRET) (Yan, et 
al 2003). For protein – protein interaction studies by both FRET and DEER, the target 
molecules are labeled with pairs of fluorescent and paramagnetic labels respectively. The 
distances measured between the labels reflect conformational differences between 
proteins (Jeschke & Polyhach, 2007). Even though FRET is more sensitive than DEER 
(Banham et al., 2006), it requires large chromophores, which must be chosen according 
to the expected distance. Contrarily, DEER distance measurements can be performed 
between identical much smaller nitroxide labels and are precise over a broader range of 
distances (Jeschke, 2002; Jeschke et al., 2004). The CW EPR can also be used to measure 
distances between two nitroxide labels (Altenbach et al., 2001), but above 2 nm it is not 
very reliable (Berliner, 2000). Therefore above 2 nm, four pulse DEER is used (Milov et 
al., 1981; Pannier et al., 2000) .  
Previously DEER spectroscopy has been applied for structural characterization of 
biomacromolecules such as membrane proteins (Dockter et al., 2009; Endeward et al., 
2009; Jeschke et al., 2005), DNA (Ward et al., 2007) and RNA (Schiemann & Prisner, 
2007; Schiemann, 2009). Distance measurements using DEER have also been done in 
filaments of α-synuclein (Karyagina et al., 2011) and hIAPP (human Islet Amyloid 
peptide) (Bedrood et al., 2011).  
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Here DEER in conjunction with SDSL was used to study the conformation of 
filaments. In the technique, SDSL is done with nitroxide labels and these labels are used 
for distance measurements. The observed distances are between the unpaired electrons at 
the end of the spin labels (Jeschke et al., 2006; Schiemann, 2009). 
4.1.2 DEER measurements. 
DEER measurements are based on alteration of the magnetic dipole-dipole 
interaction between two nitroxide spin labels by microwave pulses. Microwave pulses are 
used at two different frequencies, the observation frequency (νobserve) excites a set of spins 
in the EPR spectrum (spins X), and creates a spin echo signal. At the pumping frequency 
(νpump) a pulse excites another set of spins (spins Y), which alternates the sign of dipole-
dipole interaction between spins X and Y. Hence the electron spin echo signal (DEER 
signal) depends on the magnitude of dipole-dipole interaction between X and Y spins and 
on pumping pulse time position and intensity (Fajer et al., 2007). The four pulse echo 
sequence which was used for DEER measurement is shown in Figure 4.1.  
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Figure 4.1: Four-pulse DEER sequence. A Hahn echo (dashed purple) is produced by a 
π/2 pulse followed by a π pulse at the observer frequency (νobserve).  This echo is again 
refocused with a π pulse (purple). After the first observer π pulse, another set of spins are 
excited at pump frequency (νpump), at time t’ (blue arrow). The τ1 and τ2 are kept constant 
while t’ is sequentially stepped. When the two spins are coupled, stepping the pump pulse 
causes oscillation of the amplitude of refocused echo. The frequency of the oscillation is 
the dipolar coupling between both the spins. 
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The DEER signal V(t) contains contributions from the interaction between the two 
spins in one molecule but also from the interaction between spins on different molecules 
and is thus considered a product of two contributions 
V(t) = V(t)intra V(t)inter 
V(t)inter describes the decay due to the intermolecular interactions of unpaired spins and 
V(t)intra  describes the periodic oscillations generated by the intramolecular interactions of 
pairs of spins (Milov et al., 1984; Schiemann, 2009). For the experiments in this study, 
intermolecular interactions were reduced by diluting the sample with protein that does not 
contain paramagnetic labels. 
The pairwise dipole-dipole coupling between two spins is the basis for distance 
determination in DEER measurements. In the case of disordered system, the electron 
electron coupling (  ) is given by the sum of dipole dipole coupling (  ) and the 
exchange coupling J. In systems for which the point-dipole approximation is valid and for 
which the exchange coupling J can be assumed to be isotropic 
    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Where gA  and gB are the g values of the two spins, µB  is the Bohr magneton, µ0  is 
the permeability of free space, h is the Planck constant, r is the distance between the two 
spins and θ is the angle between the static field axis and the axis connecting the loci of 
the two electron spins. The distance measurement is based on the dependence of dipole-
dipole couplings on the inverse cube of the distance.  
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To study the conformational differences between tau filaments, DEER 
measurements were compared for double mutants of K18 grown on K18 seeds, K19 
grown on K19 seeds and K18 grown on K19 seeds. 
4.2 Methods 
4.2.1 Site directed mutagenesis, protein expression, and protein purification. 
In the site directed mutagenesis, first a single cysteine was introduced as 
mentioned in Chapter 2 section 2.1.1 and this single cysteine DNA was used as a 
template to introduce another cysteine. As these double mutants were difficult to obtain, 
miniprep plasmid purifications were performed to sort the correct size of the required tau 
DNA. The correct DNA was transformed again in XL1Blue competent cells and then 
midiprep plasmid purifications were carried out to get higher yield for DNA sequencing. 
Then protein expression and purification were performed as mentioned in chapter 2. 
4.2.2 Multistep production of seeds. 
In the initial step, filaments were formed by mixing 25 µM of cysteine free K18 
with 50 µM of heparin (average molecular mass of 5000 Da, Celsus, Cincinnati, OH) 
using elution buffer. After three days of agitation at 25°C, the filament sample was 
chilled and sonicated for 20 seconds to create seeds using Fisher Scientific Sonifier (150 
T Series). The next round of filament reaction was set up by adding 10% seeds (from the 
first reaction) to 25 µM of K18 (cysteine free) and mixed with 50 µM of heparin. 
Filaments formation was carried out at 37°C for 1 h. This procedure was repeated four 
times and each time seeds from the previous reaction were used to form next set of 
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filaments. The final seeds (4th cycle) were used in DEER sample preparation. The same 
was done to prepare K19 (cysteine free) seeds. 
4.2.3 Sample preparation for DEER experiments. 
 For the preparation of filaments for DEER measurement, the MTSL labeled 
double mutant (procedure mentioned in chapter 2) was mixed with 50 fold excess of 
cysteine free K18 or K19, 5% seeds from the 4th cycle of the multistep seeded reaction, 
and heparin (protein:heparin molar ratio of 4:1). The final protein concentration was 
50µM and fibrillization was carried out at 37°C. Before preparing the DEER sample, the 
efficacy of seeds was checked by running a control acrylodan assay with and without 
seeds as mentioned in chapter 3. For the acrylodan assay, the reaction conditions were 
similar to those used for preparation of DEER sample. After 14 hrs, the formed filaments 
were pelleted at 100,000 x g and washed once with elution buffer. To the filament pellets, 
20-50 µl of elution buffer was added to reconstitute the sample, which was then pelleted 
into a quartz capillary (1.1 mm inner diameter x 1.6 mm outer diameter) at 1000 x g. The 
buffer layer in the capillary tube above the sedimented filaments was completely 
aspirated out using a syringe. The capillary tube was flash frozen in liquid N2 and stored 
at -80°C. DEER measurements were performed within seven days of making the sample. 
4.2.4 Negative stain electron microscopy. 
The EM grids of tau filaments were prepared as mentioned in chapter 2. The tau 
filament concentration used was 5 µM. 
 
 
 
 
84 
 
4.2.5 Setting up filaments of double mutants to confirm β parallel in-register 
structure. 
 
Samples for CW EPR measurement for completely labeled K18 and K19 double 
mutants were spin labeled as described in chapter 2.  Protein concentrations used were 
~25µM. Filaments were prepared under agitation condition by mixing protein with 
heparin at a molar ratio of 4:1 and by incubating at 25°C for 3 days. Samples were 
pelleted at 100,000 x g for 30 minutes, washed with elution buffer, and transferred into 
borosilicate capillaries (0.6 mm inner diameter x 0.84 mm outer diameter). 
4.2.6 EPR and DEER measurements 
CW EPR measurements of samples were recorded with a Bruker EMX 
spectrometer fitted with an ER 4119HS resonator. Parameters for taking EPR spectrum 
are mentioned in chapter 2 section 2.2.5. Spectra were normalized to the same number of 
spins using double integration. From all spectra, a minor background arising from 0.5% 
soluble tau was subtracted.  
            DEER data were obtained at Q-band frequencies (34 GHz) with a Bruker Elexsys 
E580 spectrometer equipped with a 1-watt amplifier, a Bruker ER 5107 Q-band dielectric 
pulse resonator, and an Oxford CF 935 cryostat. Measurements were performed using 
four-pulse DEER experiment: π/2(νobs) – τ1 – π(νobs) – t’ – π(νpump) – (τ1 + τ2  – t’) - 
π(νobs)  -  τ2 – echo (Figure 4.1) (Pannier et al., 2000; Dockter et al., 2009; Jeschke et al., 
2005). For the experiment, the resonator was fully overcoupled (Q~100). All 
measurements were performed at a temperature of 80 K. The observer π/2 and π pulse 
lengths were optimized for each run and ranged from 30 - 40 ns and 60 – 80 ns 
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respectively. A pump pulse length of 40 ns was used. The τ1 and τ2 were kept constant 
and time t’ was varied. Data analysis was performed for dipolar evolution times t = t’ - τ1 
> 0. The resonance magnetic field was set at the global maximum of the nitroxide EPR 
spectrum and the pump frequency, νpump, was set to the centre of the resonator dip. The 
observer frequency, νobserver, was 37 MHz higher than νpump and coincided with of the 
center of the spectrum (Fajer et al., 2007) (Figure 4.2). The repetition time was 
calculated for each run as 1.2 times the T1 relaxation time and 8-step phase cycling was 
used. The total measurement time for each sample was between 48 – 72 hours. 
  
Figure 4.2: Field swept echo detected EPRspectrum. The pump frequency (νpump) and 
the observer frequency (νobserver) for nitroxide label in Q-band are shown for the double 
mutant K18 311/328 on K18 seeds. 
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4.2.7 DEER data analysis. 
DEER data was analyzed using “DeerAnalysis2011” (Jeschke et al., 2006). The 
program DeerAnalysis2011 can extract distance distributions from dead-time free pulse 
ELDOR data (constant-time and variable-time pulse DEER). 
Before distance distribution can be obtained from the dipolar evolution time, a 
background correction has to be performed. A background correction is performed to 
ensure that intermolecular distances are suppressed and only intramolecular distances are 
taken into account to find the distance distribution in the protein. 
4.2.7.1 Homogenous background correction. 
The general background function in this model is: 
                             B (t) = exp (-ktd/3) 
Where k quantifies the density of the spins and d is the dimensionality of the 
homogeneous distribution. The distribution is homogeneous in d= 3 dimensions for 
proteins in solution and for membrane proteins it can be confined to d= 2 (Hilger et al., 
2005; Zou & Mchaourab, 2010). For the current study 3D homogeneous background 
correction was used as it showed better background correction with singly labeled 
mutants. After the background correction, distances were extracted from the dipolar 
evolution curves using Tikhonov regularization (Jeschke et al., 2006; Jeschke & 
Polyhach, 2007). 
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4.2.7.2 Tikhonov regularization. 
The data analysis was done by Tikhonov regularization which is a non biased 
(model independent) way of finding the distance distribution (Jeschke et al., 2006; 
Jeschke & Polyhach, 2007). 
In Tikhonov regularization, the distance distribution is quantified by a 
regularization parameter α which is a compromise between smoothness (artifact 
suppression) and resolution of the distance distribution. The optimum distance 
distributions P(r) are obtained by minimizing the sum of the functions η(α) andρ(α), 
where η(α) is the square norm of the second derivative of P(r),which is a measure of 
smoothness multiplied by the regularization parameter α and ρ(α) is the mean square 
deviation between the simulated and experimental dipolar evolution time domain data. 
The larger α, lesser noise artifacts are introduced but also causes broadening of peaks in 
distance distribution. The optimum α is obtained by plotting log η(α) versus log ρ(α) 
which quantifies the mean square deviation and the smoothness. The L-curve (shape of 
the plot resembles alphabet “L”) for the data is implemented by doing Tikhonov 
regularization for a given set of regularization parameters (Chiang, et al., 2005)  
α = (0.001, 0.01, 0.1, 1, 10, 100, 1000, 10000, 100000). 
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4.3 Results 
4.3.1 Conformational templating of 4R on 3R seeds. 
We showed previously in chapter 3 that 4R was able to grow on 3R seeds, while 
3R was unable to grow on 4R seeds. To study the conformational differences between the 
filaments when grown on different seeds, DEER was used. In this method double mutants 
were created in the repeat region of the tau monomer which forms β parallel in-register 
structure and is part of the core (Margittai & Langen, 2004) (chapter 2). The double 
mutants 4R (K18-311/322, 311/326, 311/328) and 3R (K19-311/322, 311/326, 311/328) 
were created by replacing amino acids at respective positions by cysteine residues 
(K311C, 322-natural cysteine, G326C, I328C). To make sure that the replacement of 
amino acids with cysteine residues in the double mutant did not disrupt the formation of 
filaments, the double mutant monomers were labeled with MTSL and set for filament 
formation. The measurement of filaments was performed using CW EPR, and single line 
spectra were observed for all double mutants (Figure 4.3). This showed that the filaments 
of the double mutant had formed parallel in-register structure (Margittai & Langen, 
2008). 
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Figure 4.3: EPR spectra of completely labeled double mutants with MTSL. 311/322, 
311/326 and 311/328 double mutants of K18 and K19, EPR spectra were taken. Spectra 
of all filaments were recorded at 150 G width and normalized to the same number of 
spins.  
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Next, samples for DEER were prepared by mixing 2% MTSL labeled double 
mutant with cysteine free protein. As the growth of filaments was a seeded reaction, 
seeds from the 4th cycle of multistep seeded reaction were used. Also, acrylodan assays 
performed with the same parameters which were used to prepare DEER samples showed 
the formation of filaments with the seeds of the 4th cycle from the multistep seeded 
reaction. The filaments were pelleted by ultracentrifugation, taken up in EB, transferred 
into quartz capillary and sedimented at 1000 x g. After this CW EPR measurements of 
the sedimented filaments were taken. Spectral broadening of the EPR spectra was not 
observed indicating that spin labeled monomers did not preferentially stack upon 
themselves, but incorporated evenly into the filaments (Figure 4.4). Electron 
micrographs of all the mutants confirmed the presence of filaments (Figure 4.5). The 
DEER samples were flash frozen and DEER measurements were carried out for all the 
samples, K18 311/322, K18 311/326, K18 311/328 on K18 and K19 seeds; K19 311/322, 
K19 311/326, K19 311/328 on K19 seeds.  
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Figure 4.4: EPR spectra of diluted double mutants. Spectra of double mutants, 
311/322, 311/326 and 311/328 of K18 grown on K18 seeds (left column), K19 on K19 
seeds (centre column) and K18 on K19 seeds. 2% of the labeled double mutant was 
mixed with cysteine free tau protein. Spectra of filaments were recorded at 150 G scan 
width and normalized to the same number of spins. 
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Figure 4.5: Electron micrograph of filaments. Double mutants 311/322, 311/326 and 
311/328 (A) K18 grown on K18 seeds (B) K19 grown on K19 seeds (C) K18 grown on 
K19 seeds. Bar = 0.4 µm.  
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 The dipolar oscillation traces of K18 311/322 on K18 (truncated 4R) (black trace) 
and K19 seeds (truncated 3R) (blue trace), K19 311/322 on K19WT seeds (red trace) 
were obtained from DEER measurements (Figure 4.6 A). The dipolar oscillation traces 
of these three different filament growths matched with each other. The dipolar oscillation 
traces for 311/322 double mutant indicate similar spin-spin interactions for the three 
types of filaments, K18 on K18, K19 on K19 and K18 on K19 seeds. Similar spin-spin 
interactions between these double mutants indicate similar distances (Fajer et al., 2007).
 Dipolar oscillation traces of K18 311/326 grown on K18 or K19 seeds and K19 
311/326 grown on K19 seeds are shown in Figure 4.6 B. The results showed that when 
K18 311/326 was grown on K19 seeds, the dipolar oscillation trace was closer to the 
trace of K19 311/326 on K19 seeds rather than K18 311/326 grown on K18 seeds. The 
spin-spin interactions between 311 and 326 of K18 311/326 on K19 seeds were closer to 
that seen in K19 311/326 on K19 seeds. These results suggest that K18 311/326 on K19 
seeds assumes a new conformation, similar to that of its seed. The same results were 
obtained when K18 311/328 was grown on K19 seeds (Figure 4.6 C). Here, the spin-spin 
interactions were not as strong as seen when K18 311/328 was grown on K18 seeds. The 
weighted sum of the dipolar oscillation traces for singly labeled K19 for positions 311 
and 326 (Figure 4.6 B, green trace) is similar to that of doubly labeled K19 311/326 and 
K19 311/328. This indicates a longer interspin distance for K19 311/326 and K19 
311/328 doubly labeled mutants on K19 seeds when compared to K18 on K18 seeds for 
the same double mutant numbers. As a result, the data for 311/326 and 311/328 double 
mutants suggest that when K18 monomers were grown on K19 seeds, the K18 filaments 
94 
 
adopted the conformation of K19 seeds, which shows that K19 was able to 
conformationally template K18. 
 
         
 
 
Figure 4.6: Dipolar oscillation curves of labeled mutants of tau filaments. (A) 
Dipolar oscillation curves  taken for a T2 of  2.5 µs. Double mutant 311/322 of K18 
grown on K18 seeds (black), K19 grown on K19 seeds (red) and K18 grown on K19 
seeds (blue). The curves for the three mutant filaments are the same. (B) Dipolar 
oscillation curves of 311/326 mutant of K18 grown on K18 seeds, K19 grown on K19 
seeds and K18 grown on K19 seeds. The weighted sum of the dipolar oscillation curves 
for two singly labeled K19 311 and K19 326 is also shown (green). (C) The dipolar 
oscillation curves of 311/328 of K18 on K18 seeds (black trace), K19 on K19 seeds (red 
trace) and K18 on K19 seeds (blue trace).  
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4.3.2 3R and 4R tau form heterogeneous filaments. 
When the dipolar oscillation curves were fit using Tikhonov regularization to 
obtain the distance distribution, multiple peaks suggest the presence of heterogeneous 
filament mixtures. While closely spaced peaks could be the result of different rotamers, 
peaks that are spaced over ~2.0-2.5 nm might represent different filament conformers. 
4.3.2.1 Distance distribution for 4R double mutants. 
The distance distributions between two spin labels in 4R were obtained by 
Tikhonov regularization. Figure 4.7 A shows the dipolar evolution data after the 3D 
homogeneous background correction (black trace) and the Tikhonov fit (red trace) 
corresponding to the distance distribution for the double mutants K18 311/322, K18 
311/326 and K18 311/328 grown on K18 seeds. The dipolar Pake pattern obtained from 
the time trace after Fourier transformation is shown in Figure 4.7 B (black trace). After 
Fourier transformation of the data after background correction, the dipolar spectrum has 
the expected shape of a broadened Pake pattern and is well fitted by the dipolar spectrum 
corresponding to the distance distribution using Tikhonov regularization (red trace) 
(Figure 4.7 A, B) (Jeschke & Polyhach, 2007). The distance distributions when 
Tikhonov regularization parameter α was set at 100 is shown in Figure 4.7 C. Distance 
distributions in the K18 311/322 double mutant showed major component peaks at 
distances of 3.4 nm and 3.9 nm with a distribution width of 1.6 nm. For K18 311/326, the 
major component peak showed a distance of 3.6 nm with a distribution width of 1.2 nm 
while a minor component peak was at 5 nm with a distribution width of 0.9 nm. In K18 
311/328 on K18 seeds, the major component peak was at 4.8 nm with a width of 1 nm 
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while minor component peaks were at 3.3 and 3.6 nm. The L-curves are also shown for 
the three double mutants (Figure 4.8). The green marker in the L-curve highlights the 
regularization parameter α = 100. 
To make sure that the observed distance distributions were not due to noise 
artifacts, for K18 311/328, Tikhonov fits were done at different scan numbers (Jeschke et 
al., 2005; Jeschke et al., 2006).  Here the minor peaks observed were 1/3rd of the major 
peak. Even at lower scan numbers where the S/N is low, peaks were still seen at smaller 
distances of 3.4 nm and 3.9 nm apart from 4.8 nm (data not shown) confirming the 
formation of heterogeneous filaments. These results demonstrate that the Tikhonov 
distributions of the double mutants showed multiple distance distributions showing 
heterogeneity in the conformers of the filament mixture.  
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Figure 4.7: Distance distribution for filaments of K18 double mutants on K18 
seeds. (A) Dipolar evolution curve due to the double MTSL labels in the filament (black 
trace), obtained by background correction, and the fit (red) corresponding to the distance 
distribution. The data are plotted in stacks. (B) Dipolar spectrum obtained by Fourier 
transformation of background corrected data (black) and fit to the spectrum 
corresponding to the distance distribution. (C) Distance distributions obtained by 
Tikhonov regularization with regularization parameter of α = 100. Maximum heights for 
K18 311/322 = 3.4 and 3.9 nm, K18 311/326 = 3.6 nm and K18 311/328 = 3.4, 3.9 and 
4.8 nm were observed. 
 
 
 
B A 
C 
98 
 
 
 
 
 
  
 
 
 
 
Figure 4.8: Tikhonov L curves of K18 on K18 seeds. (A) K18 311/322 (B) K18 11/326 
(C) K18 311/328 templated on K18 (4R) seeds. The green data point corresponds to the 
regularization parameter α = 100 which was used to obtain the distance distribution. 
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4.3.2.2 Distance distribution of 3R double mutants. 
Tikhonov regularization fit was done for the DEER data of K19 311/322 
templated onto K19WT seeds (Figure 4.9). The L-curve is shown in Figure 4.11 A. In 
the distance distribution, the major component peak was 3.9 nm and the width of this 
distribution was 1.7 nm. For K19 311/326 and K19 311/328, we were unable to do 
Tikhonov fits to obtain distance distributions from the dipolar evolution curves as the 
spin-spin coupling was weak. As mentioned above, the dipolar oscillation traces of K19 
311/326 and K19 311/328 on K19 seeds were closer to the traces of the weighted sum of 
singly labeled K19 311 and K19 326. This clearly shows that the distance between the 
two labels is large. 
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Figure 4.9: Tikhonov regularization fit for double mutant K19311/322 templated on 
K19 (3R) seeds. Dipolar evolution curves in time (A) and frequency (B) domains.  
(C) Resulting distance distribution with a major peak at 3.8 nm. Black traces are after 
background correction of the data while the red traces show fits after Tikhonov 
regularization.  
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4.3.2.3 Distance distribution of 4R double mutant on 3R seeds. 
The Fourier transformed dipolar spectrum after 3D homogeneous background 
correction (black trace), is well fitted by the dipolar spectrum corresponding to the 
distance distribution using Tikhonov regularization (red trace) (Figure 4.10 A, B). 
Tikhonov regularization fit for K18311/322 on K19 seeds showed major component peak 
at 3.5nm with a width of 1.3 nm (Figure 4.10 C). The L-curve is shown in Figure 4.11 B 
and the green marker in L-curve is at α = 100. The distance distribution obtained for 
K8311/322 on K19 seeds was very similar to K19311/322 grown on K19 seeds and 
different from K18311/322 grown on K18 seeds.  Narrowing of the distance distribution 
was seen when K18 was grown on K19 seeds. The distance distributions obtained when 
K18 was grown on K18 seeds, K19 on K19 seeds and K18 on K19 seeds showed that the 
mixture of filaments formed was heterogeneous.  
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Figure 4.10: Tikhonov regularization fit for double mutant K18 311/322 templated 
on K19WT seeds. The seeds were formed after five cycles of seeded reaction. (A) 
Dipolar evolution curves in time and (B) frequency domains. (C) Resulting distance 
distribution with a major peak at 3.5 nm. Black traces are after background correction of 
the data while the red traces shows fits after Tikhonov regularization. 
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Figure 4.11: Tikhonov L curves. (A) K19 311/322 on K19 (3R) seeds (B) K18 311/322 
templated on K19 (3R) seeds. The green data point corresponds to α = 100. 
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4.4 Discussion 
Structural information on the PHF fibril has been obtained by different 
techniques, such as proteolysis, transmission electron microscopy (Goux, 2002; von 
Bergen et al., 2006), CD, FTIR spectroscopy (Barghorn & Mandelkow, 2002; Frost et al., 
2009) and CW EPR (Margittai & Langen, 2004; Margittai & Langen, 2006a), but insight 
into the structural arrangement of tau PHFs on the residue-specific level is still scarce. 
DEER measurements have been used in these studies as a ‘spectroscopic ruler’ to 
study conformational differences between various filaments (Jeschke et al., 2005). 
Studies in this chapter have for the first time showed molecular level structural 
differences in tau filaments using DEER measurements. For these experiments three 
different cysteine double mutants were created in K18 and K19 in the 3rd repeat region of 
the tau monomer. The 3rd repeat region is part of the core which forms the β parallel in- 
register structure in filaments. The intramolecular distances were defined by labeling the 
two cysteine residues in each double mutant by a nitroxide label and the distance 
measured was between two electrons localized in the N-O bond of the nitroxides 
(Schiemann, 2009). Variations in the intramolecular distances between filaments suggest 
differences in conformations (Fajer et al., 2007). For conformational studies by DEER, 
three different types of filaments growth were examined 1) growth of K18 monomers on 
K18 seeds 2) growth of K19 monomers on K19 seeds  and 3) growth of K18 monomers 
on K19 seeds.  
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Comparison of the dipolar oscillation curves of K18 (4R) on 4R seeds, K19 (3R) 
on 3R seeds and K18 (4R) on 3R seeds of 311/322 double mutant showed that they were 
very similar. For the double mutant 311/326, the dipolar oscillation curve of K18 (4R) 
grown on K19 (3R) seeds was different from K18 (4R) grown on K18 (4R) seeds. The 
dipolar oscillation curve of 4R on 3R seeds was closer to 3R grown on 3R seeds (Figure 
4.6 B). This showed that in this region, the conformation of 4R grown on 3R seeds was 
similar to that of 3R on 3R seeds. The 3R seeds were able to conformationally template 
4R of 311/326 double mutant. Similar results were obtained for 311/328 double mutant 
(Figure 4.6 C). DEER measurements confirmed the conformational templating of 4R on 
3R at the molecular level.  
The dipolar evolution data were fit using Tikhonov regularization which is an 
unbiased way to fit data compared to other fitting programs available in DEER Analysis 
2011(Jeschke et al., 2006). Homogeneous background correction to account for 
intermolecular interactions was done using d=3 dimensions. This spatial background 
correction was used for the double mutants because it showed better background 
correction with singly labeled mutants. The obtained distance distributions by Tikhonov 
regularization for the double mutants showed that the filaments formed were 
heterogeneous in nature. For the K18 on K18 seeds, double mutant 311/322 showed 
distance distribution from 2-5.3 nm with peaks at 3.4 and 3.9,  311/326 double mutant 
showed a distance distribution from 2.2 -5.3 nm with peak at 3.6 nm and for 311/328, 2-
5.3 distance distribution was observed with peaks at 3.4, 3.9 and 4.8 nm.  For the 
experiments, the seeds used for templating of the monomers were prepared by going 
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through multiple steps of seeded reactions as it had already been shown that samples with 
a homogeneous mixture of filaments could be prepared by repetitive seeded growth 
(Paravastu et al., 2008).  Distance distributions of samples showed that the mixture of the 
double mutant formed were heterogeneous even after templating the double mutant onto 
the seeds from the 4th cycle of the multistep seeded reaction. Since the distance 
distributions observed were really broad, the actual distances may not be just because of 
the rotamer conformation of the spin label alone (Jeschke et al., 2005). During analysis of 
raw data using DEER Analysis 2011, smaller peaks at the base line could be seen which 
might denote noise artifacts (Jeschke et al., 2004). As observed in the distance 
distributions of double mutants,  the smaller peaks in 311/322 and 311/326 double mutant 
may be ignored (Dockter et al., 2009) (Figure 4.7 A, B). In the K18 311/328 double 
mutant distance distribution, observed peaks at 3.4 nm and 3.9 nm are almost one 3rd of 
the highest peak at 4.8 nm (Figure 4.7 C). To check whether the smaller peaks were 
noise related, Tikhonov regularization fits were done at various scan numbers. The lower 
scan numbers with lower S/N showed the same heterogeneous distribution. These broad 
distributions may not be attributed to intermolecular interactions between nitroxide labels 
of different strands. To avoid intermolecular interactions between spin labels only 2% of 
the double mutant was labeled. As already mentioned, the interstrand distance between 
two β-strands is 4.8 Å, and hypothetically if the double mutant was incorporated after 
every 48th strand in the filament, the distance would be ~23nm which is much larger than 
the distances measured.  
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The distance distribution of K18 311/322 on K19 seeds was similar to K19 
311/322 on K19 seeds than to K18 311/322 on K18 seeds. The distance distribution of 
K19 311/326 on K19 seeds could not be obtained. The dipolar oscillation curve of K19 
311/326 on K19 seeds mutant is similar to the dipolar oscillation curve of the weighted 
sum of singly labeled 311 and 326. Hence, the distance between 311 and 326 in the K19 
double mutant is more than 5.5 nm (Jeschke et al., 2006). When the Tikhonov 
regularization fit for distance distribution was done for K18 311/326 on K19 seeds, peaks 
were observed at 2.8 and 4 nm. When the dipolar oscillation curves were looked at in 
Figure 4.6 B for K18 311 326 on K19 seeds, the curve was closer to K19 311 326 on 
K19 seeds. This led to the conclusion that the maximum population of K18 311 326 on 
K19 seeds has a conformation which is similar to K19 311 /326 on K19 seeds. Therefore, 
the majority of conformers of K18 311/326 on K19 seeds have really long distances. For 
the double mutant 311/328 (K18, K19) on K19 seeds, Tikhonov regularization fits could 
not be done to obtain distance distribution. Here we may not exclude the presence of 
distances larger than 5 nm, which would be suppressed by the background correction for 
2.5 µs evolution time. All of the above obtained distance distributions by DEER have 
shown that the filaments form heterogeneous mixture, K18 when grown on K19 looks 
more like K19 on K19 seeds rather than K18 on K18 seeds. The results have also shown 
that DEER could be a very good technique to study structural polymorphism in fibrils. 
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Solid state NMR was first used to study molecular level polymorphism in β-
amyloid fibrils of AD (Petkova et al., 2005). Similar polymorphism now has been 
documented by solid-state NMR for α-synuclein fibrils (Heise et al., 2005), amylin 
(IAPP) fibrils (Madine et al., 2008) and other amyloid fibrils (Paravastu et al., 2006).  
Previous studies on conformational templating differences between seeded 
reactions in tau filaments at the structural level have been shown based on circular 
dichroism spectroscopy (CD) and FTIR (Frost et al., 2009). These studies by CD and 
FTIR showed differences based on the secondary structures (β-sheet, random coil, α-helix 
and random coil) seen in tau filaments. Differences in the filament fragilities and 
morphologies based on the electron microscopy also helped in studying the structural 
differences. Though the mentioned studies have shown structural differences, the 
differences were not as dramatic as shown by our DEER studies at molecular level.  
Studies of structural polymorphism in tau filaments due to conformational 
differences at the molecular level are important because it has been shown that in 
sporadic tauopathies, phenotypic diversities are seen due to conformational differences in 
wild type tau filaments (Frost et al., 2009; Legname et al., 2006; Tanaka et al., 2004b). 
Also structural polymorphism has been seen in multiple amyloid forming proteins due to 
formation of distinct conformers based on template conformation change (Petkova et al., 
2005; Yamaguchi et al., 2005).  
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Evidence available in prion disease has suggested that there is a strong link 
between the conformation of a fibrillar protein and the resultant phenotype (Bessen & 
Marsh, 1994; Legname et al., 2006; Peretz et al., 2002). When prion monomers from one 
species were cross-seeded with preformed fibrils from another species, a new amyloid 
strain was produced which showed the secondary structure and morphology of the 
template fibrils. Conformational differences which were strain-specific because of cross-
seeding were also found in yeast Sup35 prion amyloid fibrils by FTIR and EPR spectra 
(Tanaka et al., 2005). It has also been suggested that prion populations comprised of 
variety of conformers with the same sequence, constitutes ‘quasi-species’, from which 
the one replicating most efficiently in a particular environment is selected. The transfer of 
prions between cell types within the same species involves a selection of favored 
‘substrains’, and propagation of prions in the presence of an inhibitory drug can result in 
the appearance of drug-resistant prion populations (Weissmann et al., 2011).  
A very recent study in mice has shown that the transfer of tau filaments between 
synapses of neurons causes the spread of neurodegenerative disease (Liu et al., 2012).  
We have shown in our study that there are innumerable number of compositionally 
(Siddiqua & Margittai, 2010) and conformationally distinct filaments of tau (Dinkel et 
al., 2011). There might be some species of tau conformers which might be more 
infectious than the others as shown in prion populations and hence structural 
polymorphism could be a major contributor to the diversity of tauopathies.  
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 Studies have also shown that in AD, the appearance of NFTs of tau correlates 
really well with the symptoms of the disease, while the same is not seen with β-amyloid 
plaques (Braak et al., 1994; Liu et al., 2012).  Since most of the drugs which were 
targeted at β-amyloid have failed (Medina, 2011), this research work on basic 
understanding of tau filament structures is a stepping stone in coming up with better 
treatments targeted at molecular clearances of the filaments (Cohen & Kelly, 2003). The 
findings of our research in understanding structural polymorphism of tau filaments are 
highly significant in the ongoing research in neurodegenerative diseases and their 
treatments. 
. 
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Appendix A 
RECIPES 
 
NZY media 
 
NaCl 5 g 
MgSO4*7H2O 2 g 
Bacto-yeast extract 5 g 
NZ amine (casein 
hydrolysate) 
10 g 
Total volume 1L 
pH  7.5 
 
 
 
NZY+ media 
 
NZY media 
 
MgCl2 12.5 mM 
MgSO4 12.5 mM 
Glucose 20 mM 
 
 
 
LB Media 
 
LB Broth 25 g 
Kanamycin 30 mg 
Total volume 1.5L 
 
 
 
Kanamycin-LB Agar plates 
 
LB Broth 20 g 
LB Agar 15 g 
Kanamycin 50 mg 
Total volume 1.0 L 
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Extraction buffer 
 
NaCl 500 mM 
PIPES (pH 6.5) 20 mM 
EDTA (pH 8.0) 5 mM 
Total volume 1L 
 
 
 
 
PIPES buffer 
 
PIPES 302.37 g Conc. 1M 
pH 6.5 
 
Total volume 1L 
 
 
 
 
 
Buffer A for ion exchange 
 
NaCl 50 mM 
PIPES (pH 6.5) 20 mM 
EDTA 0.5 mM 
DTT 2 mM 
 
 
 
 
Buffer B for ion exchange 
 
NaCl 1000 mM 
PIPES (pH 6.5) 20 mM 
EDTA 0.5 mM 
DTT 2 mM 
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Gel Filtration buffer 
 
NaCl 100 mM 
Tris (pH 7.0) 20 mM 
EDTA 1 mM 
DTT 2 mM 
 
 
 
 
SDS Running buffer  
 
1X 
 
Glycine 28.8 g 
Tris base 6.04 g 
SDS 2 g 
Total volume 2 L 
 
 
 
SDS-PAGE 4x Sample Buffer 
 
Reagent Final Concentration Volume Mass 
80% Glycerol 40% 5ml 
 
1M Tris-Cl, pH 6.8 240 mM 2.4ml 
 
SDS 8% 
 
0.8 g 
Bromophenol blue 0.1% 
 
4 mg 
H2O  2.1ml  
 
 
 
 
SDS-PAGE Gel buffers 
 
4X Lower gel buffer 1.5 M Tris-Cl (pH 8.8) 
 
0.4% SDS 
  
4x Upper gel buffer 0.5 M Tris-Cl (pH 6.8) 
 
0.4% SDS 
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12% SDS PAGE Gel (For 2 Gels) 
 
 
Separation Gel (Lower)(12%) Stacking (Upper)(4%) 
Acryl-Bisacrylamide 4 ml 1.3 
Tris-Cl (pH 6.8) 
 
2.5 
Tris-Cl (pH 8.8) 2.5 ml 
 
10 % SDS 0.1 ml 0.1 
dH2O 3.4 ml 6.1 
10% APS 50 µl 50 µl 
TEMED 5 µl 10 µl 
 
 
 
 
15% SDS PAGE Gel (For 2 Gels) 
 
 
Separation Gel (Lower)(15%) Stacking (Upper)(4%) 
Acryl-Bisacrylamide 5 ml 1.3 
Tris-Cl (pH 6.8) 
 
2.5 
Tris-Cl (pH 8.8) 2.5 ml 
 
10 % SDS 0.1 ml 0.1 
dH2O 2.4 ml 6.1 
10% APS 50 µl 50 µl 
TEMED 5 µl 10 µl 
 
 
 
 
Coomassie blue stain solution 
 
Coomassie blue  2.5 g 
methanol 200 ml 
Acetic acid 50 ml 
dH2O 250 ml 
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Destain solution 
 
Glacial Acetic acid 125 ml 
Methanol 50 ml 
Total volume 1L 
 
 
 
1X TBE buffer for Agarose Gel Electrophoresis 
 
Tris base 1 M 
Boric acid 1M 
EDTA 20 mM 
 
 
 
 
HEPES Buffer 
 
HEPES 260.28 Conc. 1M 
pH  7.4 
 
Total volume 1L 
 
 
 
 
 
Elution Buffer (EB) 
 
NaCl 100 mM 
HEPES (7.4 pH) 10 mM 
NaN3 0.1 mM 
Total volume 1L 
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Appendix B 
Genscript QuickClean 5M PCR Purification Kit protocol of PCR product 
purification purification 
1. The PCR reaction sample was transferred to a 1.5 ml microcentrifuge tube and 
400 µl of binding solution was added and thoroughly mixed. 
2. The above mixture was transferred to a column and centrifuged at 12,000 rpm for 
one minute. 
3. The flow –through was discarded and 500 µl of wash solution was added to 
column. The column was then centrifuged at 12,000 rpm for 30 seconds. 
4. To remove the residual amount of wash solution, the column was centrifuged for 
an additional one minute. 
5. The column was transferred to a clean 1.5 ml microcentrifuge tube. To the centre 
of the column membrane 30 µl of the elution buffer was added and incubated at 
room temperature for one minute. To collect the DNA the column was 
centrifuged again for one minute. The eluted DNA in the microcentrifuge tube 
was stored at -20°C. 
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Qiagen® Midiprep Plasmid Purification kit 
1. For starter culture a single colony was picked for bacterial growth in LB medium 
with 30 mM kanamycin and kept in the shaking incubator at 37°C for 17 hrs. 
2. Bacterial cells were harvested at 6000 x g for 15 minutes at 4°C. 
3. The bacterial pellet was resuspended in 4 ml Buffer P1. 
4. To the resuspended bacterial pellet, 4 ml of Buffer P2 was added, mixed 
thoroughly by vigorously inverting the sealed tube 4-6 times, and incubated at 
room temperature (15-25°C) for 5 minutes 
5. To the above mixture, 4 ml of chilled Buffer 3 was added and immediately mixed 
by vigorously inverting 4-6 times. The sample was incubated on ice for 15 
minutes. 
6. After 15 minutes, the sample was centrifuged for 20,000 x g for 30 minutes at 
4°C. The supernatant which has the plasmid DNA was removed immediately. 
7. The supernatant was centrifuged again at 20,000 x g for 15 minutes at 4°C. The 
supernatant containing the plasmid was removed promptly. 
8. QIAGEN-tip 100 was equilibrated by applying 4 ml of Buffer QBT and allowed 
the column to empty by gravity flow. 
9. The supernatant from step 7 was applied to the QIAGEN-tip and allowed it to 
enter the resin by gravity flow. 
10. The QIAGEN-tip was washed 2 times with 10 ml Buffer QC.  
11. The DNA was eluted with 5 ml of Buffer QF. 
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12. The DNA was precipitated by adding 3.5 ml of isopropanol, mixed and 
centrifuged immediately at 15,000 x g for 30 minutes at 4°C. After centrifugation 
the supernatant was carefully decanted. 
13. The DNA pellet was washed with 1.8 ml of room temperature 70% ethanol and 
centrifuged at 15,000 x g for 10 minutes. The supernatant was carefully decanted 
without disturbing the pellet. 
14. The pellet was air dried and redissolved in TE buffer of pH 8.0. 
 
GenScript Quickclean 5M Miniprep kit protocol for plasmid purification 
1. For overnight culture a single colony was picked and put into a polypropylene 
tube with 5 ml LB medium and 30 mM kanamycin and kept in the shaking 
incubator at 37°C for 17 hrs for bacterial growth. 
2. From the overnight culture, 1.5 ml was transferred to 1.5 ml microcentrifuge tube 
and centrifuged at 12,000 rpm for 30 seconds. The supernatant was discarded. 
This was continued until all the bacteria were pelleted from the overnight culture. 
3. To the pellet 100 µl of solution I was added and the cells were resuspended. The 
cells were resuspended by running the narrow end of the microcentrifuge tube 
along an empty microcentrifuge storage rack. 
4. To the mixture 200 µl of solution II was added. The solution was mixed gently by 
inverting the tube 4-6 times. 
5. After this 300 µl of solution III was added and mixed gently by inverting the tube 
4-6 times.  
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6. The sample was centrifuged at 12,000 rpm for five minutes and the supernatant 
was transferred to the column. The column was centrifuged for 30 seconds at 
12,000 rpm. 
7. The flow through was discarded and 500 µl of the wash solution was added and 
centrifuged for 30 seconds. 
8. The flow through was discarded and the column was centrifuged for additional 60 
seconds to remove the residual wash solution 
9. The column was transferred to a clean 1.5 ml microcentrifuge tube. To the centre 
of the column 30 µl of the elution buffer was added and allowed the column to 
stand at room temperature for one minute. After one minute the column was 
centrifuged at 12,000 rpm for one minute. The eluted sample which has the 
plasmid DNA was stored at -20°C until further use. 
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Appendix C 
Protein concentration determination was done using the Lambert Beer’s law: 
A Full length tau protein concentration determination was done at 280 nm: 
A=εcl 
Molar extinction coefficient of full length tau: 7395 mol-1Lcm-1, path length of the 
cuvette = 1cm.  
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Appendix D 
Cation exchange method parameters 
 
Mono S 10 GL 100 method on Unicorn 5.11 was used to purify proteins by ion exchange 
 
 
Flow rate (ml/min) 3 
 
Column Pressure limit 
(mPa) 
3 
 
Averaging time for UV 2.60 
 
Fraction size (ml) 3 
Gradient segment 1 Target conc (%B) 15 
 
Length of gradient (CV) 3 
 
Fraction size (ml) 3 
Gradient segment 2 Target conc (%B) 60 
 
Length of gradient (CV) 8 
 
Fraction size 3 
Gradient segment 3 Target conc (%B) 100 
Gradient delay (ml) 
 
5 
Clean after elution (CV) 
 
5 
 
 
 
Gel filtration parameters 
 
Manual run was used in Unicorn 5.11.  
 
Flow rate (ml/min) 5 
Fraction size (ml) 5 
Column Pressure limit (MPa) 0.8 
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Appendix E 
Protein concentration measurement by Pierce® BCA Protein Assay kit 
1. Bovine serum albumin (BSA) standards were prepared from 2000 µg/ml to 62.5 
µg/ml 
2. Working reagent of BCA was prepared by mixing 50ml Reagent A with 1ml of 
Reagent B 
3. Test-tube Procedure in the protocol was used to find the concentration of the 
unknown protein 
4. 85 µl of each standard and unknown sample were pipetted in appropriately 
labeled test tube 
5. 1.7 ml of the working reagent was added to each tube and mixed well 
6. The Standard Protocol was followed. The tubes were incubated for 30 minutes at 
37°C. 
7. All the tubes were cooled to room temperature 
8. The absorbance of the samples was measured at 562 nm with water as the blank. 
9. Standard curve was plotted and the protein concentration of the unknown was 
determined.  
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